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Abstract
In practice, survival data are often grouped into clusters, such as clinical sites, geograph-
ical regions and so on. This clustering imposes correlation among individuals within each
cluster, which is known as within cluster correlation. For instance, in our motivating ex-
ample, within each long term care facility (LTCF), the elderly are likely from nearby areas
with similar quality of life and having access to similar health care. As such, individual
sharing the same hidden features may correlate with each other. The shared frailty model
is therefore often used to take into account the correlation among individuals from the same
cluster. In some applications, when the survival data are collected over geographical regions,
random effects corresponding to geographical regions in closer proximately to each other
might also be similar in magnitude, due to underlying environmental characteristics. There-
fore, shared spatial frailty model can be adopted to model the spatial correlation among the
clusters, which are often implemented using Bayesian Markov Chain Monte Carlo method.
This method comes at the price of slow mixing rates and heavy computational cost, which
may reader it impractical for data intensive application.
In this thesis, motivated by the computational challenges encountered in modelling spatial
correlation in a real application involving large scale survival data, we used simulations
to assess the efficiency loss in parameter estimates if residual spatial correlation is present
but using a spatially uncorrelated random effect term in the model. Our simulation study
indicates that the share frailty model with only the spatially correlated random effect term
may not be sufficient to govern the total residual variation, whereas the simpler model with
only the spatially uncorrelated random effect term performs surprisingly well in estimating
ii
the model parameters compared with the true model with both the spatially correlated and
uncorrelated random effect terms. As such, using the shared frailty model with independent
frailty term should be reliable for estimating the effects of covariates, especially when the
percentage of censoring is not high and the number of clusters is large. Also, such model
is advantageous, since it can be easily and efficiently implemented in a standard statistical
software. This is not to say that the shared frailty model with independent frailty term
should be preferred over the spatial frailty model in all cases. Indeed, when the primary goal
of inference is predicting the hazard for specific covariates group, additional care needs to be
given due to the bias in the scale parameter associated with the Weibull distribution, when
the correlation structure is misspecified.
iii
Acknowledgements
Firstly, I would like to express my sincere gratitude to my supervisor Dr. Cindy Xin Feng,
and my co-supervisor Dr. Susan Whiting for their guidance, encouragements, patience and
continuous support during my M.Sc. study. I offer my sincere appreciation for the learning
opportunities provided by my supervisors. This thesis could not have been written without
their invaluable advice and patient guidance.
I would also like to thank the rest of my thesis committee: Dr. Longhai Li, Dr. Michael
Szafron and my external examiner, Dr. Xulin Guo for their valuable comments.
My especial thanks go, as well, to Dr. Mohammad Owais Suria, a physician, also a
master’s student at the University of Saskatchewan. I had the opportunity and honor to
work with him on several projects. His enthusiasm and motivation to do research and his
admirable confidence have always inspired me. His encouragements, advice and guidance in
last two years have been invaluable to me and have opened a new horizon in my academic
life.
My sincere thanks also goes to Dr. Catherine Trask for offering me the summer internship
opportunity. I also would like to thank Dr. Hassan Vatanparast for the opportunities working
on the research projects using various statistical methods.
Finally, I would especially like to thank my wife, Najmeh Eshghi, and my parents and
siblings for their love, support and constant encouragement over the years. You are the salt
of the earth, and I undoubtedly could not have done this without you.
iv
I dedicate this thesis to my patient wife, Najmeh.
v
Contents
Permission to Use i
Abstract ii
Acknowledgements iv
Contents vi
List of Tables viii
List of Figures x
List of Abbreviations xi
1 Introduction 1
1.1 Background and Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Survival Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.2.1 Survival and Hazard Functions . . . . . . . . . . . . . . . . . . . . . 5
1.2.2 Accelerated Failure Time Model . . . . . . . . . . . . . . . . . . . . . 6
1.3 Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2 Shared Frailty Model 10
2.1 Hip Fracture Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
2.1.1 Study Population and Design . . . . . . . . . . . . . . . . . . . . . . 10
2.1.2 Potential Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.2 Shared Frailty Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.2.1 Model Formulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.2.2 Statistical Inference . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2.3 Hip Fracture Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.3.1 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.3.2 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
3 Shared Spatial Frailty Model 30
3.1 Model formulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.2 Bayesian Inference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.2.1 Gibbs Sampling Formulation . . . . . . . . . . . . . . . . . . . . . . . 33
3.2.2 Model Comparison Criteria . . . . . . . . . . . . . . . . . . . . . . . 35
3.3 Bayesian Model Checking Strategies . . . . . . . . . . . . . . . . . . . . . . . 36
3.4 Hip Fracture Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
3.4.1 Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
vi
4 Simulation Studies 43
4.1 Simulation Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
4.2 Simulation Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
5 Conclusion and Future Work 61
A Appendix 64
A.1 Optimization Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
A.1.1 Adaptive Gaussian Quadrature Optimization . . . . . . . . . . . . . . 64
A.1.2 Quasi-Newton Optimization . . . . . . . . . . . . . . . . . . . . . . . 65
B Appendix 66
B.1 Verification of Weibull Assumption . . . . . . . . . . . . . . . . . . . . . . . 66
Bibliography 70
vii
List of Tables
2.1 Distribution of the characteristics of the elderly over age 65 from the LTCFs,
BC, Canada, 2010− 2014. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.2 Distribution of the characteristics of the elderly over age 65 from the LTCFs
who developed hip fracture vs. those who did not, BC, Canada, 2010− 2014. 22
2.3 The bivariate analysis reporting the estimated hazard ratios (HR), the corre-
sponding 95% confidence interval (CI) and p-values for all the potential risk
factors in the hip fracture analysis. . . . . . . . . . . . . . . . . . . . . . . . 24
2.4 The multivariate analysis of the the hip fracture data using the Weibull model
with independent frailty term. The table reports the estimated hazard ratio
(HR) and the corresponding 95% confidence intervals (CI) and p-values for all
the significant risk factors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
3.1 Posterior means (Mean), standard deviations (SD), 95% credible intervals (CI)
and the hazard ratios (HR) of the estimated parameters for the non-spatial
frailty model. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.2 Posterior means (Mean), standard deviations (SD), 95% credible intervals (CI)
and the hazard ratios (HR) of the estimated parameters for the spatial frailty
model. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.3 Posterior means (Mean), standard deviations (SD), 95% credible intervals (CI)
and the hazard ratios (HR) of the estimated parameters for the full model. . 41
3.4 Bayesian posterior predictive p-values for three discrepancy measurements de-
fined in (3.12) and (3.13). . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
3.5 Deviance information criterion (DIC) for competing models of in the hip frac-
ture data analysis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4.1 Percent relative bias (%RB), mean square error (MSE) and coverage proba-
bility (CP) of the estimated λ based on the non-spatial model, spatial model
and the full model, when the data is simulated from the full model. The true
value for λ = 0.55. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
4.2 Percent relative bias (%RB), mean square error (MSE) and coverage proba-
bility (CP) of estimator of ρ based on the non-spatial model, spatial model
and the full model, when the data is simulated from the full model. The true
value for ρ = 1.5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
4.3 Percent relative bias (%RB), mean square error (MSE) and coverage proba-
bility (CP) of estimator of β1 based on the non-spatial model, spatial model
and the full model, when the data is simulated from the full model. The true
value for β1 = 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
4.4 Percent relative bias (%RB), mean square error (MSE) and coverage proba-
bility (CP) of the estimated β2 based on the non-spatial model, spatial model
and the full model, when the data is simulated from the full model. The true
value for β2 = 1.5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
viii
4.5 Percent relative bias (%RB), mean square error (MSE) and coverage proba-
bility (CP) of the estimated σ2V based on the non-spatial model, spatial model
and the full model, when the data is simulated from the full model. The true
value for σ2W = 5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
4.6 Percent relative bias (%RB), mean square error (MSE) and coverage probabil-
ity (CP) of the estimated σ2W based on the non-spatial model, spatial model
and the full model, when the data is simulated from the full model. The true
value for σ2V = 4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
4.7 Posterior mean, %95 credible interval (CI) and Rˆ for the estimated λ based
on the non-spatial model, spatial model and the full model, when the data is
simulated from the full model. The true value for λ = 0.55. . . . . . . . . . . 52
4.8 Posterior mean, %95 credible interval (CI) and Rˆ for the the estiamted ρ based
on the non-spatial model, spatial model and the full model, when the data is
simulated from the full model. The true value of ρ = 1.5. . . . . . . . . . . . 52
4.9 Posterior mean, %95 credible interval (CI) and Rˆ for the estimated β1 based
on the non-spatial model, spatial model and the full model, when the data is
simulated from the full model. The true value of β1 = 2. . . . . . . . . . . . 53
4.10 Posterior mean, %95 credible interval (CI) and Rˆ for the estimated β2 = 1.5
based on the non-spatial model, spatial model and the full model, when the
data is simulated from the full model. The true value of β2 = 1.5. . . . . . . 53
4.11 Posterior mean, %95 credible interval (CI) and Rˆ for the estimated σ2W based
on the spatial model and the full model, when the data is simulated from the
full model. The true value for σ2W = 5. . . . . . . . . . . . . . . . . . . . . . 54
4.12 Posterior mean, %95 credible interval (CI) and Rˆ for the estimated σ2V based
on the non-spatial model and the full model, when the data is simulated from
the full model. The true value of σ2V = 4 . . . . . . . . . . . . . . . . . . . . 54
ix
List of Figures
1.1 A hip fracture is a break in the thigh bone or femur of the hip joint. The left
picture exhibits the Femoral neck fracture which is the most common type of
hip fracture and the right picture shows Intertrochanteric hip fracture. . . . 2
4.1 Boxplots of the posterior mean estimates of λ, where σ2V = 4 . . . . . . . . . 55
4.2 Boxplots of the posterior mean estimates of ρ, where σ2V = 4 . . . . . . . . . 56
4.3 Boxplots of the posterior mean estimates of β1, where σ
2
V = 4 . . . . . . . . . 57
4.4 Boxplots of the posterior mean estimates of β2, where σ
2
V = 4 . . . . . . . . . 58
4.5 Boxplots of the posterior mean estimates of σ2V , where σ
2
V = 4 . . . . . . . . 59
4.6 Boxplots of the posterior mean estimates of σ2W , where σ
2
V = 4 . . . . . . . . 60
B.1 log(− log(S(t))) vs. log(t) with no covariate considered . . . . . . . . . . . . 67
B.2 log(− log(S(t))) vs. log(t) with age and sex covariate considered . . . . . . . 68
B.3 log(− log(S(t))) vs. log(t) with age, sex and falls history covariate considered 69
x
List of Abbreviations
SCUBA Self Contained Underwater Breathing Apparatus
LOF List of Figures
LOT List of Tables
xi
Chapter 1
Introduction
1.1 Background and Motivation
Hip fracture is a fracture of the proximal femur, either through the femoral cervix or through
the trochanteric region 1.1. In Canada, up to 28% and 37% of men and women, respectively,
die in the first year following hip fracture, mostly as a result of serious underlying medical
conditions [1]. Survivors, on the other hand, will barely regain the level of function they had
prior to the hip fracture as 44% of people discharge from hospital for a hip fracture return
home; of the rest, 10% go to another hospital, 27% go to rehabilitation care, and 17% go to
long-term care facilities (LTCFs) [1]. As well, one third of survivors re-fracture within one
year and half of them re-fracture within five years after the primary event of hip fracture.
Hip fracture incidence increases with age in elderly people over 65 such that more than 80%
of people who experience hip fracture are over 50 years of age. In Canada, around 30,000
people experience hip fracture which is more than incidence frequency of heart attack, stroke
and breast cancer combined, while currently only 14% of Canada’s population are over 65
[2]. Consequently, each hip fracture costs the health care system $21,285 in the first year
after hospitalization, and $44,156 if the patient is institutionalized [3]. The total health care
budget spent on hip fracture is $1.2 billion. It is estimated that the elderly population will
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increase up to 24% in Canada’s population and hip fracture expenditure alone on health care
will cost $2.4 billion in 2041 [3].
Figure 1.1: A hip fracture is a break in the thigh bone or femur of the hip joint. The
left picture exhibits the Femoral neck fracture which is the most common type of hip
fracture and the right picture shows Intertrochanteric hip fracture.
Among geriatric population, those who cannot live independently at home due to chronic
illnesses, or decline in physical or cognitive functions are most likely brought to long term
care facilities (LTCFs) or other residential-based care facilities. LTCFs offer 24 hour, 7 day a
week nursing services to their residents, most of whom live permanently in the facility until
death. This population, thus, is more vulnerable than community with the same age such
that they tend to develop hip fracture 4 times more and fall 3 times more than elderly people
in community [4]. The estimated prevalence of hip fracture in LTCFs is approximately 20%,
and is even higher as residents approach 90 years of age or older [5]. Residents who suffer
from a hip fracture are less likely to regain function than elderly people in community, and
are twice as likely to die within 3 months as those without fracture [6]. Conclusively, hip
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fracture contributes in substantial suffering for the patient living in these facilities, as well
as a severe economic burden for society [7].
Despite much research has been conducted to identify the risk factors associated with
hip fracture, few research has been conducted to fully utilize the information on time from
entering into the LTCFs until the first time the elderly people got hip fracture [8, 9]. Such
information on time to event is critical to evaluate the quality of the health care delivered at
LTCFs. The shared frailty models can be utilized to incorporate the within cluster correla-
tion in modeling the time to event data [10, 11]. Furthermore, recent studies [12, 13, 14] have
suggested seniors from rural areas tend to have a higher risk of getting hip fracture compared
with those from urban areas, suggesting that risk of hip fracture could potentially be geo-
graphically dependent. If macro-environmental factors are contributing to the risk of getting
hip fracture among the elderly at the LTCFs, then differential risk of hip fracture should be
expected within a large geographic area in which variation in these factors is present. Hence,
for seniors residing in the LTCFs in close proximity to each other, we would expect some
degree of residual spatial correlation in the risk of getting hip fracture after adjustment for
patient-level characteristics known to be associated with hip fracture.
To date, no study has investigated spatial patterns of initial hip fracture in elderly re-
siding in LTCFs. The shared spatial frailty model [15, 16] controls for unmeasured spatial
confounders by including a flexible baseline that is spatially varying. This approach allows
us to borrow information across spatial units to estimate the baseline hazard, which is of-
ten implemented using Bayesian Markov Chain Monte Carlo method; however, this method
comes at the price of slow mixing rates and heavy computational cost, which may reader it
impractical for data intensive application. Therefore, the objectives of this thesis include:
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(1) modeling time to first hip fracture among elderly people from LTCFs in British Columbia
to determine the risk factors associated with the hazard of having the first hip fracture based
on the shared frailty survival model; (2) testing if there is any spatial correlation in the
residual after accounting for individual level risk factors; and (3) through simulation studies,
investigating if there is any bias and efficiency loss in the estimated regression coefficients
under the models with misspecified correlation structures and if the bias and efficiency loss
depend on the percentage of censoring, the number of clusters and relative strength of the
residual spatial correlation.
1.2 Survival Analysis
Survival analysis is a branch of statistics that focuses on modeling time duration between a
starting point until a specific endpoint, such as from birth until death in biological organisms,
time to recovery after being diagnosed with certain disease or time to failure in mechanical
systems [17].
In many situations, we do not observe the event for all individuals included in a study.
A survival time is right censored when the individual did not develop the disease of interest
by the end of study, or left the study due to immigration or death or other reasons than the
event of interest. Left censoring is when the event of interest has already occurred before
enrollment. Interval censored data arises when the failure time cannot be observed, but can
only be determined to lie in an interval obtained from a sequence of examination times. The
right censoring is the most common type of censoring in many applications [18].
The time interval between an individual entering in the study until experiencing the event
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of interest or loss to follow up (due to some reason other than the disease of interest) are
called survival time and censored time, respectively.
1.2.1 Survival and Hazard Functions
Let T denote the survival time following distribution f(t). Survival function is defined as the
probability of not experiencing the event between time t:
S(t) = P (T > t) = 1− P (T ≤ t) = 1− F (t). (1.1)
which is a non-increasing function of t with S(0) = 1, 0 < S(t) < 1.
The hazard function is another commonly used distribution function for describing the
survival time [19] which is defined as:
h(t) = lim
∆→0
P (t ≤ T < t+ ∆|T ≥ t)
∆
, (1.2)
which calculates the instantaneous failure rate at time t, given that the individual survives
until time. This function is simplified by applying the conditional probability formula:
h(t) = lim
∆→0
P (t ≤ T < t+ ∆)
∆
1
P (T ≥ t) =
dF (t)
dt
S(t)
=
f(t)
S(t)
. (1.3)
The hazard function must be non-negative, h(t) ≥ 0, and its integral over [0,∞) must be
infinite, but is not otherwise constrained; it may be increasing or decreasing, non-monotonic,
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or discontinuous. One can also write
h(t) =
dF (t)
dt
1− F (t) = −
d log(1− F (t))
dt
. (1.4)
which implies
S(t) = e−
∫ t
0 h(s)ds. (1.5)
Cumulative hazard, H(t) is another important function in survival analysis which is defined
as
H(t) =
∫ t
0
h(s)ds, (1.6)
which implies that
S(t) = e−H(t). (1.7)
Therefore, by knowing either of f(t), F (t), h(t), S(t) or H(t), other functions can be derived.
1.2.2 Accelerated Failure Time Model
To model the effect of covariates on the survival time, popular choices of regression models to
incorporate the covariates are the proportional hazards model [20, 21], the additive hazards
model [22], the proportional odds model [23] and the accelerated failure time model [24].
This thesis will focus on accelerated failure time models.
In accelerated failure time (AFT) models, we assume that the effect of the covariates will
be a multiplication of the expected survival time. For AFT models, it is common to use the
log-linear representation
Yi = log(Ti) = µ+α
′Xi + σi, (1.8)
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where µ is the intercept, α are unknown regression coefficients reflecting the effect that each
explanatory variable has on the survival time and Xi is a vector of covariates, σ is the scale
parameter and i is the error term, i = 1, · · · , n. The distribution of the error term, i is
assumed to be known, and determines the distribution of T and vice versa.
Weibull is one of the mostly used distributions in survival analysis. It is the only distri-
bution that can be expressed as both an accelerated failure time model and a proportional
hazard model. If T follows a Weibull distribution,  has a Gumbel distribution [19] with the
survival function e−e

.
The probability distribution function of T under a Weibull distribution is specified by
f(ti) = λiρt
ρ−1
i e
−λitρi . (1.9)
Assuming the log-linear form (1.8) for the survival times, the survival function can be
expressed as,
S(ti) = P (µ+α
′Xi + σi ≥ log(ti)) (1.10)
= P
(
i ≥ log(ti)− µ−α
′Xi
σ
)
(1.11)
= Si
(
log(ti)− µ−α′Xi
σ
)
(1.12)
= e−e
log(ti)−µ−α′Xi
σ (1.13)
= e−λit
1/σ
i (1.14)
where λi = e
(
−µ−α′Xi
σ
)
, which is the scale parameter for the Weibull distribution, so the
covariates can be included within λi and the parameter ρ = 1/σ provides the shape of the
7
distribution.
Therefore, the hazard function for the Weibull regression is expressed as:
h(ti) = f(ti)/S(ti) = ρt
ρ−1
i λi = ρt
ρ−1
i e
β′Xi , (1.15)
where β = (β0, β1, ..., βp)
′ such that β0 =
−µ
σ
and βi =
−αi
σ
, for i = 1, ..., p and p is the number
of risk factors. Weibull regression also belongs to the proportional hazard family, since the
covariates are multiplicatively related to the hazard [25].
Let δi denote the event indicator for the ith subject, i = 1, · · · , n, where δi = 1 if the ith
individual experienced the event and δi = 0 if censored. The likelihood function can be then
written as
L(θ|t, δ,X) =
n∏
i=1
f(ti)
δi
(
S(ti)
)1−δi . (1.16)
where θ = (β, ρ)′ denotes the vector of parameters in the model, t = {ti}ni=1 denotes the
collection of times to event or censoring and δ = {δi}ni=1 is the collection of event indicators
for all subjects and X is the collection of all the covariates. The likelihood function can be
also written as,
L(θ|t, δ,X) =
n∏
i=1
h(ti)
δiS(ti). (1.17)
For the Weibull regression model, the likelihood function can be then expressed as,
L(θ|t, δ,X) =
n∏
i=1
(
ρtρ−1i e
β′Xi
)δi exp (−tρi eβ′Xi). (1.18)
The maximum likelihood estimators (MLE) of the parameters can be obtained by taking the
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derivatives of the log likelihood with respect to the parameters, which are consistent and
asymptotically normal [26].
1.3 Overview
The remaining of the thesis is organized as follows: Chapter 2 introduces shared frailty model
and its mathematical formulation, maximum likelihood estimation and inference, which is
followed by an analysis of hip fracture data. Chapter 3 introduces the shared spatial frailty
model to test if there is any residual spatial correlation. In Chapter 4, we conduct a simula-
tion study to understand if there is any bias and efficiency loss in the estimated regression
coefficients under the models with misspecified correlation structure. Further, how the bias
and efficiency loss depend on the percentage of censoring, the number of clusters and the
relative strength of the spatial correlation. Chapter 5 concludes the thesis with conclusions
and future works.
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Chapter 2
Shared Frailty Model
In the first section of this chapter, an introduction to the hip fracture data and the
potential risk factors for hip fracture will be provided. In the next section, the shared frailty
model formulation will be presented, followed by application of this model on the hip fracture
data.
2.1 Hip Fracture Data
2.1.1 Study Population and Design
The cohort of the study includes 36629 seniors who are above 65 years of age and entered
LTCFs from January 2010 to December 2014 in the the province of British Columbia (BC),
Canada. The study population comes from 298 LTCFs. Canadian hospitals and acute care
facilities record information about admitted individuals. The individuals were assessed every
three months and the data were recorded. This information comprises demographic informa-
tion, diagnosis of related diseases, date of entry and discharge of the patients and so forth.
The information periodically is submitted to the Canadian Institute for Health Information
(CIHI) by acute care facilities and/or regional health authorities (RHAs) in all territories
and provinces except Quebec. CIHI, accordingly, records these data in databases such as
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Discharge Abstract Database (DAD), Continuing Care Reporting System (CCRS), Hospital
Morbidity Database (HMD) and National Ambulatory Care Reporting System (NACRS).
DAD and CCRS are the main sources used in this research to retrieve information for the
individuals.
2.1.2 Potential Risk Factors
For many years, osteoporosis was the only well-known cause of fractures in geriatric popula-
tion. Osteoporosis is a medical condition in which the bones become brittle and fragile from
loss of tissue. One way of diagnosing osteoporosis is to determine the bone mineral density
(BMD). If BMD is 2.5 or more below the BMD of a 30 years old healthy adult, the individual
has osteoporosis. Despite the osteoporotic people are extremely prone to fracture, majority
of fractures occur in people without osteoporosis [27]. The immediate conclusion, thus, is
that BMD score does not provide the only source for prediction of hip fracture and efforts
must be made to recognize all the risk factors which are independent from osteoporosis. On
the other hand, 90% of those who get hip fracture is due to falling [28]. That is, even if the
person has osteoporosis, hip fracture would not happen if the patient does not fall. If falls
can be prevented in LTCFs, the long-term survival and quality of life of seniors in LTCFs
can be extended [29]. Henceforth, risk factors which result in falls must be detected as well
as their contribution to hip fracture risk.
The potential demographic risk factors for hip fracture are age over 65, female gender
[30], geography region [31], and the possible non-demographic factors including low body
mass index (BMI) [32], falls [33], co-morbidities [34], and poly-pharmacy [35], calcium and
vitamin D deficiency [36, 37] and etc.
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A short review of these risk factors is presented as follows:
Osteoporosis
Annually, more than 8.9 million fractures occur worldwide due to osteoporosis [38]. Os-
teoporosis is a condition that causes bones to become thin and porous, decreasing bone
strength and leading to an increase in risk of breaking a bone [39]. In Canada, osteoporosis
causes 70-90% of 30,000 hip fractures annually. One of the reasons is that the osteoporosis
is undiagnosed. As an evidence for this, 80% of patients with a history of fractures are not
given osteoporosis diagnosis or therapies [1]. Therefore, the focus has increasingly been on
the identification of patients at high risk of fracture rather than the identification of people
with osteoporosis by BMD.
Age
Age is one the most important risk factors of osteoporosis, especially in women. In recent
decades, the incidence of hip fracture has gone up substantially partly due to the extended
life expectancy. Between 1990 and 2000, there was nearly a 25% grow in hip fractures world-
wide [40]. In Canada, 80% of hip fractures happen in people over 50 years of age [1] and 52%
of hip fractures occur in the age group 80 and over [41].
Sex
It is shown that women have higher chance of getting hip fracture than men due to higher
life expectancy and experiencing menopausal which both increase risk of osteoporosis [42].
Worldwide, 1 in 3 women over age 50 will experience osteoporotic fractures, as will 1 in 5
men aged over 50 [43]. Overall, 70% and 61% of hip and osteoporotic fractures occur in
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women.
BMI
Low body mass index (binomial) is a well-documented risk factor for future fracture,
whereas a high BMI is widely believed that obesity is protective against fracture [44]. BMI
is also one of determinants of bone mineral density (BMD) [45] so that the higher BMI, the
lower is the risk of osteoporosis. In obese people, a protective layer of fat padding around
the hip may protect the bone from fracture [46].
Falls
Although bone and muscle weaknesses, low bone mineral density (BMD) and osteoporosis
are most prominent predictors of hip fracture in literature, more than 90% of hip fractures
in elderly population take place as a consequence of falls [28]. The evidence highlight the
substantial negative impact of falls on the quality of life of Canadians and Canada’s health
care system [47]. Even a minor fall or injury can lead to a fracture for someone, especially
with osteoporosis highlighting the importance of fall predictors and fall prevention. Evidence
indicates that falls may interact with geographical regions, socio-economic status, so forth
[46, 48, 49, 50, 51]. Therefore, it is vital to identify risk factors of falls resulting in hip
fracture. Major risk factors of falls in the elderly include functional decline, musculoskeletal
problems, neurological diseases, psychosocial characteristics and medications [52].
Poly-pharmacy
Polypharmacy, usually defined as the concurrent use of multiple medications [53]. Elderly
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population are more prone to multiple medical conditions, such as hypertension, arthritis,
heart disease, cancer, and diabetes mellitus, which require multiple medications for proper
treatment [54]. Residents of LTCFs, also, are not exceptional and, as a matter of fact,
consume a relatively higher volume of medications while residing in LTCFs [55]. Studies
have demonstrated that the use of multiple medications enlarges the hazard of adverse drug
effects, drug-drug interactions, electrolyte imbalance, decreased drug clearance rates, and
impaired balance [56, 57]. The probability of potential drug interactions is markedly related
to the number of medications used. When 2 drugs are taken per day, the potential for drug
interactions is approximately 6%; however, the risk rises to 50% with 5 drugs per day and
is as high as 100% with 8 drugs per day [58]. The main group of drugs resulting in these
drug complications are benzodiazepines, antidepressants, antipsychotics and antiepileptics
[59]. As a result, polypharmacy increases the risk of falls higher than twofold [60, 61] and
consequently increases the risk of hip fracture [35]
Geographical Region
The incidence of hip fracture also varies throughout the world. Statistics show that
Scandinavian countries have the highest fracture rate comparing with other regions of the
globe [62, 63, 64, 65]. Within North America, the United States is categorized as ‘very high’
fracture risk, similar to the Scandinavian countries and Iceland and Canada is categorized
as ‘high’ fracture risk, similar to Great Britain [63].
The risk of hip fracture may also vary within a smaller geographic area. There is a general
trend of the risk of hip fracture being higher in urban areas [66], which might be attributed
to the longer life expectancy, more mobility and even poorer nutrition intake for the residents
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in the urban areas [67, 68]. However, evidence in literature is mixed with some reports that
reveal higher risk in urban areas. Some studies have reported higher risk in urban areas [69],
and other study report no significant difference [70].
Co-morbidities
Patients with hip fracture frequently have multiple illnesses [71]. Such people may take
multiple medications for the sicknesses they carry, they become depressed, get anxiety and
other possibilities may happen which inflate risk of falls. Various studies have shown impact
of certain diseases in inflation of hip fracture risk: rheumatoid arthritis [72], diabetes [73],
sedentary life style [74], cognitive impairment [75] and dementia [76], Alzheimer’s [77], hy-
potension and stroke [78], and Parkinson’s disease [79].
Size of LTCF
Size of an LTCF indicates the number of seniors living in the LTCFs and defined based
on the number of beds having three categories: small: ≤ 30 beds; medium: 30 > and ≤ 100;
large: > 100.
Small sized and medium facilities are more likely to suffer from the lack of expert nurses,
professional doctors and having access to high-level care their residents may need. As a re-
sult, incidence of different clinical outcomes may be higher in such facilities than large ones
[80].
Other Factors
Other factors, at individual, facility or even regional level, may be influential in developing
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hip fracture which may not be retrievable. Examples of such factors include socio-economic
status, Vitamin D and Calcium intake, glococorticoid, parental history of fracture, alcohol
consumption and smoking. WHO report (2008) [38] gives a comprehensive overview of these
risk factors along with other factors.
2.2 Shared Frailty Model
In practice, survival data are often collected from certain groups or clusters within which
individuals tend to share common characteristics, i.e. gene traits, environmental effects,
socio-economic status and so forth. For instance, in our motivating example, within each
LTCF, the elderly are likely from nearby areas with similar quality of life, having access to
the similar doctors, nurses and drug plans and even similar activities. As such, individuals
sharing the same hidden features may correlate with each other. The shared frailty models
[10, 11] are utilized in the hip fracture analysis to take into account the within cluster
correlation.
2.2.1 Model Formulation
Let tij be the time to event or censoring for subject j in stratum i, j = 1, · · · , ni, i = 1, · · · , n.
Let Xij be a vector of individual-specific covariates. The shared frailty model has the generic
form as follows:
h(tij) = h0(tij)e
β′Xij+Vi , (2.1)
where h0(tij) is the baseline hazard, which is affected only multiplicatively by the exponential
term involving the covariates and Vi is the stratum-specific random effect term capturing the
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correlation among the individuals within each cluster. Typically, Vi follows an independent
and identically distributed (iid) normal distribution, with mean zero and variance σ2V . In this
thesis, the focus is on Weibull frailty model, which is one of the mostly used frailty model
in survival analysis. In Weibull frailty model, we assume the baseline survival time follows a
Weibull distribution:
h0(tij) = λρt
ρ−1
ij , (2.2)
where λ and ρ are the scale and shape parameters.
Hazard ratio (HR) is the ratio of hazards of the event of interest for two categories of a
risk factor, which is often used in survival analysis to describe to what extent the covariate
can shorten the time to event.
2.2.2 Statistical Inference
In this section, a quick review of the estimation and inference procedures for a full parametric
shared frailty model with Weibull baseline hazard will be given.
When positing the baseline time to follow the Weibull distribution with shape ρ, and
scale λ parameters, the likelihood function is given by
L(β, ρ, σ2V |t, δ,X,V ) =
n∏
i=1
ni∏
j=1
(
ρtρ−1ij e
β′Xij+Vi
)δij exp (−tρijeβ′Xij+Vi), (2.3)
where λ being absorbed as the intercept in the fixed part of the regression, β0 = log(λ).
The random effects Vi are unobserved which cannot be estimated directly by the observed
data. Taking average of the likelihood function over the random effects will result in the
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unconditional or marginal likelihood (probably not in a closed form) which only depends on
the regression parameters, i.e. the Weibull shape and regression parameters and the variance
component. Therefore, the maximum likelihood estimates can be evaluated based on the
unconditional likelihood function.
The first step to approximate the parameters is to integrate out the unobserved terms.
Hence, the resulting unconditional likelihood will form
L(β, ρ, σ2V |t, δ,X) =
∫
IRn
L(β, ρ, σ2V |t, δ,X, V1, ..., Vn) dV1...dVn =
n∏
i=1
ni∏
j=1
∫ ∞
−∞
(
ρtρ−1ij e
β′Xij+Vi
)δij exp (−tρijeβ′Xij+Vi)φ(Vi|σ2V ) dVi, (2.4)
where Vi follow normal distribution with mean zero and variance σ
2
V .
The solution to this integral is not in a closed form. Hence, methods such as Taylor series
expansion, importance sampling and adaptive quadrature Gaussian rules method have been
proposed to approximate the likelihood function [81, 82, 83]. In adaptive Gaussian quadrature
method, the summand is calculated at Q predetermined quadrature points z?q (q = 1, ..., Q)
over the random sample Vi. The Gauss-Hermite weights wq and quadrature points z
?
q can be
obtained from tables (e.g. Abramowitz and Stegun 1964, table 25.10) [84]. In this thesis, as
also recommended by [82], the adaptive Gaussian quadrature integral approximation will be
used. A short description of this method is presented in A.1. The NLMIXED procedure was
utilized in SAS to maximize an approximation to the likelihood integrated over the random
effects (2.4).
Once the approximation is performed, the maximum likelihood estimates of parameters
can be found by utilizing conventional optimization techniques such as quasi-Newton opti-
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mizations. This method is also computationally efficient for medium to large-scale problems
such as ours. This technique needs more steps to converge, but since there is no need to
calculate the second order derivatives, each step is evaluated much faster compared to the
Newton-Raphson method [85]. This method is also not sensitive to the initial values while
the Newton-Raphson and gradient descent may fail for non-convex problems with an inap-
propriate starting point [86].
2.3 Hip Fracture Data Analysis
2.3.1 Results
Descriptive statistics of potential risk factors for the first hip fracture since entering the
LTCFs in BC are given in Table 2.1. This table shows the distribution of seniors in LTCFs
across different categories of the risk factors considered in our analysis.
In our study, age was stratified into three categories: 65-79 as the youngest group, 80-89
as middle age, and ≥ 90 as the oldest group. The individual level income is not provided,
so neighborhoods after-tax income level categorized as below average (less than $26, 500),
average ($26, 500-$47, 700) and above average income (greater than $80, 200)[87], was used
as a proxy of the individual level income. To evaluate an overall effect of commodities on
hip fracture, a variable was constructed as to whether a senior suffers from at least two of
the diseases: diabetes, hypotension, arthritis, alzheimer’s, dementia, parkinson’s disease, and
seizure, which are shown to be significantly associated with hip fracture [71]. Polypharmacy
is another potential risk factor for hip fracture, but none of our databases contain reliable
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information regarding the prescription drugs. Nevertheless, CCRS records the number of
days in the last week on antipsychotic, antianxiety and antidepressant drugs, which were
used to create an indicator variable which compares more than 2 days on such drugs versus
less than 2 days. Having experienced hip fracture before entering an LTCF might also be
an indicator of a hip fracture after entering to the LTCF. In our study, we considered two
measurements of falls with one being defined as within one month prior to the first assessment
in a LTCF and the other being defined as fall in last five months before a month prior to
the first assessment in a LTCF. BMI was calculated based on self-reported information on
weights and heights measured during the assessments by the nurses in LTCFs, which was
categorized as under-weight (less than 18.5 kg/m2), normal (between 18.5 kg/m2 and 25
kg/m2), over-weight (between 25 kg/m2 and 30 kg/m2), and obese (over 30 kg/m2).
Overall, 3219 out of 36629 patients in our cohort (8.79%) experienced hip fracture during
the course of our retrospective study. The median years of residing in LTCFs for our cohort
is 2.03 (95% CI 2.00-2.05). Demographic and non-demographic characteristics of the study
population by hip fracture status are presented in Table 2.2. We have adopted Weibull
shared frailty model for this analysis and the Weibull assumption is examined by checking
the log(− log(S(t))) vs. log(t) plot. If the model is correct, the dots should fall into a straight
line. In Figure B.1, a slight curvature in the line can be observed, but is not strong enough to
seriously violate the Weibull assumption and such curvature may be explained by covariates.
Therefore, we also generated similar plots by stratifying the data according to the different
combinations of risk factors. For example, as depicted in Figure B.2, by stratifying the data
by age and sex, and further in Figure B.3, by stratifying the data by age, sex and fall history,
the curvatures are quite minor, which indicate satisfaction of Weibull assumption. As such,
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we proceed with the bivariate and multivariate analyses based on the Weibull frailty model.
Table 2.1: Distribution of the characteristics of the elderly over age 65 from the
LTCFs, BC, Canada, 2010− 2014.
Characteristics Levels N Percentage 95% CI
Age 65-79 7582 20.7 (20.28, 21.11)
80-89 17560 47.94 (47.43, 48.45)
≥90 11487 31.36 (30.89, 31.84)
Sex Male 12227 33.38 (32.9 , 33.86)
Female 24402 66.62 (66.14, 67.10)
Fall in last month No 30860 84.25 (83.88, 84.62)
Yes 5769 15.75 (15.38, 16.12)
Fall 6 months before No 29473 80.46 (80.06, 80.87)
until last month Yes 7156 19.54 (19.13, 19.94)
Prior hip fracture No 35108 95.85 (95.64, 96.05)
Yes 1521 4.15 (3.95 , 4.36)
Co-morbidities ≤1 23331 63.7 (63.2 , 64.19)
≥2 13298 36.3 (35.81, 36.80)
Number of days on ≤2 15254 41.64 (41.14, 42.15)
psychiatric medication ≥3 21375 58.36 (57.85, 58.86)
BMI Obese 4479 12.23 (11.89, 12.56)
Over weight 9533 26.03 (25.58, 26.48)
Normal weight 18244 49.81 (49.3 , 50.32)
Under weight 4373 11.94 (11.61, 12.27)
Income Above average 11106 30.32 (29.85, 30.79)
Average 8657 23.63 (23.20 , 24.07)
Below average 16866 46.05 (45.54, 46.56)
Rural-Urban Rural 2844 7.76 (7.49 , 8.04)
Urban 33785 92.24 (91.96, 92.51)
Facility size Large 21128 57.68 (57.18, 58.19)
Medium 14863 40.58 (40.07, 41.08)
Small 638 1.74 (1.61 , 1.88)
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Table 2.2: Distribution of the characteristics of the elderly over age 65 from the LTCFs
who developed hip fracture vs. those who did not, BC, Canada, 2010− 2014.
Characteristics Levels hip fracture
Yes No
N % 95% CI N % 95% CI
Age 65-79 525 1.43 (1.31, 1.56) 7057 19.27 (18.86, 19.67)
80-89 1681 4.59 (4.37, 4.80) 15879 43.35 (42.84, 43.86)
≥90 1013 2.77 (2.60, 2.93) 10474 28.59 (28.13, 29.06)
Sex Females 2388 6.52 (6.27, 6.77) 22014 60.1 (59.60, 60.60)
Males 831 2.27 (2.12, 2.42) 11396 31.11 (30.64, 31.59)
Fall in last month Yes 690 1.88 (1.74, 2.02) 5079 13.87 (13.51, 14.22)
No 2529 6.9 (6.64, 7.16) 28331 77.35 (76.92, 77.77)
Fall 6 months before Yes 715 1.95 (1.81, 2.09) 6441 17.58 (17.19, 17.97)
until last month No 2504 6.84 (6.58, 7.09) 26969 73.63 (73.18, 74.08)
Prior hip fracture Yes 188 0.51 (0.44, 0.59) 1333 3.64 (3.45, 3.83)
No 3031 8.27 (7.99, 8.56) 32077 87.57 (87.23, 87.91)
Co-morbidities ≤1 1999 5.46 (5.22, 5.69) 21332 58.24 (57.73, 58.74)
≥2 1220 3.33 (3.15, 3.51) 12078 32.97 (32.49, 33.46)
Number of days on ≤2 1210 3.3 (3.12, 3.49) 14044 38.34 (37.84, 38.84)
psychiatric medication ≥3 2009 5.48 (5.25, 5.72) 19366 52.87 (52.36, 53.38)
BMI Under weight 203 0.55 (0.48, 0.63) 4276 11.67 (11.34, 12.00)
Normal weight 664 1.81 (1.68, 1.95) 8869 24.21 (23.77, 24.65)
Over weight 1900 5.19 (4.96, 5.41) 16344 44.62 (44.11, 45.13)
Obese 452 1.23 (1.12, 1.35) 3921 10.7 (10.39, 11.02)
Income Below average 1442 3.94 (3.74, 4.14) 15424 42.11 (41.60, 42.61)
Average 749 2.04 (1.90, 2.19) 7908 21.59 (21.17, 22.01)
Above average 1028 2.81 (2.64, 2.98) 10078 27.51 (27.06, 27.97)
Rural-Urban Rural 286 0.78 (0.69, 0.87) 2558 6.98 (6.72, 7.24)
Urban 2933 8.01 (7.73, 8.29) 30852 84.23 (83.86, 84.60)
Facility size Small 58 0.16 (0.12, 0.20) 580 1.58 (1.46, 1.71)
Medium 1377 3.76 (3.56, 3.95) 13486 36.82 (36.32, 37.31)
Large 1784 4.87 (4.65, 5.09) 19344 52.81 (52.30, 53.32)
The bivariate relationships of the potential risk factors with the hazard of hip fracture
are shown in Table 2.3. All variables with p-values for the unconditional association was
< 0.20 were considered in building the final model. The results of the multivariate analysis
(Table 2.4) indicate that the risk of HF for the seniors who entered LTCFs between 80-90
years of age is 1.32 (95% CI: 1.19-1.45) times higher as compared with those who are 65-79.
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Similarly, the hazard of getting HF for those over 90 years of age is 1.22 (95% CI: 1.09-1.36)
times higher as compared with those who are aged 65-79. In addition, risk of developing
HF among females is 1.24 (95% CI: 1.14-1.34) times higher than males. Risk of HF among
those who had experienced falls in last month before entering an LTCF vs. those who had
not experienced falls is 1.58 (95% CI: 1.45-1.73). Moreover, hazard of HF among those who
had experienced falls within last six-one months before entering an LTCF vs. those who had
not is 1.09 (95% CI: 1.000 -1.18). A prior HF almost doubles the risk of HF, 1.98 (95% CI:
1.71-2.30). The elderly with more than one Co-morbidities vs. at most one co-morbidity
carry more risk of HF with the hazard of HF elevated by 16% (95% CI: 1%-16%). Having
taken a psychiatric medication more than three days before entering a LTCFs vs. less than
three days inflates hazard by 8% (95% CI: 8%-25%). The hazard ratios for people who are
under-weight, normal and over-weight vs. obese people are 1.57 (95% CI: 1.34-1.83), 2.44
(95% CI: 2.11-2.83) and 2.86 (95% CI: 2.41-3.38), respectively, so being obese tends to have
a protective effect against hip fracture. Hazard of HF for seniors who registered to LTCFs
in rural areas vs. those who enter urban areas is 20% (95% CI: 10%-30%) more. Comparing
seniors living in average and high income neighborhoods reveals no significant difference (p-
value = 0.3720), while the hazard of HF in seniors living in low income neighborhoods is
almost 9% less than those who live in high income neighborhoods (95% CI: 1%-11%, p-value
= 0.0311).
To determine if the frailty term improves the model fit, we compared the Weibull frailty
model with the Weibull model without frailty term in terms of AIC. The Weibull frailty model
gives much lower AIC = 26633 than the Weibull model without the random effect term, AIC
= 26649. This implies that there is some unmeasured confounders at the LTCF level. The
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comparison is further confirmed by the likelihood ratio test (p-value = < 0.0001). Also, to
verify the Weibull assumption for the baseline survival time, log(− log(S(t))) versus log(t)
were plotted, stratified by several covariates including age and sex (B.1-B.3). Lines do not
fall perfectly on straight lines, but they are straight enough to confirm that this assumption
is not violated [19].
Table 2.3: The bivariate analysis reporting the estimated hazard ratios (HR), the
corresponding 95% confidence interval (CI) and p-values for all the potential risk factors
in the hip fracture analysis.
Characteristic Levels HR 95% CI P-value
Age 80-89 vs 65-79 1.43 (1.30, 1.58) < .0001
≥90 vs. 65-79 1.42 (1.28, 1.58) < .0001
Sex Females vs. Males 1.29 (1.19, 1.39) < .0001
Fall in last month Yes vs. No 1.68 (1.55, 1.83) < .0001
Fall 6 months before Yes vs. No 1.21 (1.11, 1.31) < .0001
until last month
Prior hip fracture Yes vs No 2.13 (1.83, 2.46) < .0001
Co-morbidities ≥2 vs. ≤1 1.09 (1.02, 1.17) 0.0133
Number of days on ≥3 vs. ≤2 1.15 (1.07, 1.23) < .0001
psychiatric medication
BMI Under weight vs. Obese 1.59 (1.35, 1.86) < .0001
Normal weight vs. Obese 2.55 (2.20, 2.94) < .0001
Over weight vs. Obese 3.05 (2.59, 3.60) < .0001
Income Average vs. High 0.95 (0.86, 1.04) 0.2420
Low vs. High 0.90 (0.83, 0.98) 0.0134
Rural-Urban Rural vs. Urban 1.21 (1.06, 1.35) 0.00032
Facility size Small or Medium vs. Large 1.10 (1.02, 1.17) 0.0102
2.3.2 Discussion
Results of the previous section shows that older ages, female sex, history of falls and hip
fracture, Co-morbidities, psychiatric drugs, higher income or socio-economic status, lower
BMI and being a resident of rural areas are significant predictors of hip fracture in seniors
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Table 2.4: The multivariate analysis of the the hip fracture data using the Weibull
model with independent frailty term. The table reports the estimated hazard ratio (HR)
and the corresponding 95% confidence intervals (CI) and p-values for all the significant
risk factors.
Characteristic Levels HR 95% CI P-value
Age 80-89 vs. 65-79 1.32 (1.19, 1.45) < .0001
≥90 vs. 65-79 1.22 (1.09, 1.36) < .0001
Sex Females vs. Males 1.24 (1.14, 1.34) < .0001
Fall in last month Yes vs. No 1.58 (1.45, 1.73) < .0001
Fall 6 months before Yes vs. No 1.09 (1.00, 1.18) 0.0485
until last month
Prior hip fracture Yes vs. No 1.98 (1.71, 2.30) < .0001
Co-morbidities ≥2 vs. ≤1 1.08 (1.01, 1.16) 0.0283
Number of days on ≥3 vs. ≤2 1.16 (1.08, 1.25) < .0001
psychiatric medication
BMI Under weight vs. Obese 1.57 (1.34, 1.83) < .0001
Normal weight vs. Obese 2.44 (2.11, 2.83) < .0001
Over weight vs. Obese 2.86 (2.41, 3.38) < .0001
Income Average vs. High 0.96 (0.86, 1.06) 0.3720
Low vs. High 0.91 (0.84, 0.99) 0.0311
Rural-Urban Rural vs. Urban 1.25 (1.11, 1.43) < .0001
σ2V 1.09 (1.02, 1.16) 0.0145
λ 1.02 (1.01, 1.02) < .0001
ρ 2.14 (2.09, 2.19) < .0001
25
after entering LTCFs. These results more or less confirm the findings of other researchers
for predicting hip fracture incidence, but the results vary in magnitude which reinforces the
importance of such an independent research on LTCFs’ dwellers rather than community
residents.
Our analysis showed that age group 80-89 is most prone to HF compared to 65-79 and over
90 groups. The literature showed the risk of HF increases by aging as a general trend. For
instance, in Canada, a report in 2005 showed that incidence of HF arises substantially with
age for both men and women [88]. However, for institutionalized residents, different results
have been reported. A systematic review [89] indicated small to no association between age
and hip fracture risk, whereas a study in Ontario revealed that risk of fracture is higher
among ≥85 age group. In another recent study from Ontario, a similar pattern as our study
revealed that HF incidence declines in the extremely older group. The less number of HF in
the extremely older group may be attributed to the prevalence of frailty and immobility in
this age group which bound seniors on bed, resulting in a decrease in risk of falls and sudden
movements.
With regards to the effect of gender on HF, our study revealed higher risk of hip fracture
among women. Similar findings were reported in other studies evaluating the HF risk for the
residents in the LTCFs from Ontario [8, 9]. As well, they identified higher rates among males,
but only in higher age group, which might be partly due to comparatively higher prevalence
of frailty among male 85 years and older. However, we did not observe a significant interac-
tion between age groups and sex in our study. The overall higher prevalence of HF among
females as compared to males is probably attributable to a significantly higher proportion of
women carrying conditions considered as risk factors for HF such as osteoporosis, dementia,
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fracture of extremities, and rheumatologic diseases as compared to men [90], while signifi-
cantly higher proportions of men have diabetes, respiratory, heart, and renal diseases that
have comparatively low risk for HF [91].
Fall is one of the most important factors associated with HF among the elderly population.
Evidence has shown that fall happens more frequent among institutionalized residents than
senior community dwellers [92, 93]. Our results revealed that the hazard of getting first HF
is 58% higher if fall occurred within one month prior to the first assessment in a LTCF, and
only 9% with the senior experienced fall in preceding six months excluding immediate last
30 days before the first assessment. These results are consistent with other studies, which
revealed that the frequency of falls is higher among institutionalized residents, e.g. half of
elderly individuals fall more than once in LTCFs [92, 93].
Our study also found that history of HF prior to entering LTCFs nearly doubles the hazard
of HF. Prior history of fracture has been reported among LTCFs residents as a moderate
risk factor, though [94, 95]. In a recent meta analysis on the general population [8], reported
prior HF is a moderate risk factor. Nevertheless, these results admit a lower risk than our
results probably due to conducting studies on general population and also due to variation
in methodology used in these studies.
Low BMI is a well-documented risk factor for HF, whereas a high BMI appears to be
protective [32, 38, 96]. Our findings indicate that risk of hip fracture decreases with the
increased BMI. A recent meta analysis based on 25 prospective cohorts also showed higher
BMI has a protective effect on HF[97]. From a clinical point of view, a protective layer of
fat padding around the hip may protect the bone from fracture [46]. We also speculate that
obese seniors are at lower risk of falls, since they tend to be less mobile than seniors with
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normal weights. [98].
In addition, to study the effect of drugs on hazard of hip fracture, we considered the
number of days on three psychiatric drugs, i.e. antipsychotic, antianxiety and antidepressant.
Although a wide spectrum of drugs being used may predict time-to-hip fracture, we only
considered use of psychotropic drugs alone due to limited information on all medications
taken. Moreover, psychiatric conditions such as dementia, Alzheimers, depression are very
common reason for LTCFs admission [55]. In our analysis, we found that the use of either
of the three psychiatric drugs for 3 or more days inflates the risk of hip fracture for about
18 percent compared to 2 or less days on these drug. Similar to our findings, several studies
have demonstrated that the use of multiple medications increases the risk of adverse drug
effects, drug-drug interactions, electrolyte imbalance, decreased drug clearance rates, and
impaired balance [56, 57]. The probability of potential drug interactions is markedly related
to the number of medications used. When 2 drugs are taken per day, the potential for drug
interactions is approximately 6%; however, the risk rises to 50% with 5 drugs per day and
is as high as 100% with 8 drugs per day [58]. The main group of drugs resulting in these
drug complications are benzodiazepines, antidepressants, antipsychotics and anti-epileptics
[59]. As a result, polypharmacy increases the risk of falls higher than twofold [60, 61] and
consequently increases the risk of hip fracture. However, our results do show only small
decrease (18%) of hazards among this vulnerable population. Considering differences in
methodology and geography, further studies are warranted to further explore the impact of
medications on HF in LTCFs.
In the context of geographical variation in HF epidemiology, various published reports
describe different role of urban or rural on incidence of HF. In literature, urban settings
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predominantly showed higher incidence rates of HF than rural settings [12, 13, 14]. These
findings are more sensible in large cities [66]. However, these reports are for general popula-
tion and not specific to elderly or LTCFs residents. Reports exploring link between HF and
urban and rural differences from Canadian jurisdictions are scarce for the community dwellers
and even not yet reported for the LTCFs. Urban-rural status may also result in different
health care outcomes which are indirectly correlated with incidence of HF [99, 100, 101, 102].
Despite general pattern of higher HF occurrence in urban areas, some studies revealed
mixed patterns. For example, Oslo, Norway, an urban city that shows high incidence rate of
HF compared to other rural Norwegian areas [103], whereas from the same country, another
study showed no significant difference in HF between urban and rural areas [12]. A study
from Poland with two third rural proportion revealed significantly contrasting result that
the risk of HF is higher in the rural areas than the urban areas [104]. In Asia, a study
in Shiraz, an Iranian city, showed that the HF rate was higher in the urban areas than
the rural areas[105], but a study from Shanghai city in China, which is a typical megapolis
center revealed relatively lower rates in the urban areas as compared to the rural areas. The
differences in methodology, recruitment criteria and the targeted study populations may lead
to the mixed findings [106]. In our study, residents from the LTCFs located in the rural
areas had higher risk of HF than those from the urban areas, which might implies the lack
of adequate health care provided in the LTCFs in the rural areas.
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Chapter 3
Shared Spatial Frailty Model
In practice, survival data are often collected over clinical sites or geographical regions. In
this case, random effects corresponding to geographical regions in closer proximity to each
other might also be similar in magnitude, due to environmental characteristics, necessitating
further epidemiology study [15, 16]. As shown in Chapter 2, the seniors from the rural areas
are at a higher risk of getting hip fracture as compared with the seniors from the urban areas.
This may imply a potential spatial effect among the LTCFs. The aim of the data analysis
in this chapter is to provide an illustrative example by applying shared spatial frailty model
on the hip fracture data. In order to model the spatial correlation among the LTCFs, only a
few covariates can be included in the model due to the limitation of computation rescouses
involved in Bayesian Markov Chain Monte Carlo inference approach, as introduced in Section
3.2. Here, we are particularly interested in studying the association of falls and the risk of
hip fracture; therefore, we chose falls as the primary risk factor of interests and age, prior
hip fracture and residential region (rural versus urban) as the confounding variables. We
conducted the analysis for males and females separately due to the computational burden in
modeling the large scale survival data.
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3.1 Model formulation
Let tij be the time to event or censoring for subject j in stratum i, j = 1, · · · , ni, i = 1, · · · , n.
Let X ij be a vector of individual-specific covariates. The general form of shared spatial and
non-spatial frailty model is then defined as,
h(tij) = h0(tij)e
β′Xij+Wi+Vi , (3.1)
where h0(tij) is the baseline hazard which can be assumed to be ρt
ρ−1
ij e
β0 and is affected
only multiplicatively by the exponential term involving the covariates and Wi is the stratum-
specific random effect term capturing the spatial correlation among the strata, which can be
modeled as a conditional autoregressive (CAR) structure (Besag et al, 1991) [107],
Wi|W∂i ∼ N(W ∂i , σ2W/mi), (3.2)
where ∂i represents the neighbours of the i
th region, W ∂i is the average of Wi′ 6=i that are
adjacent to Wi and mi is the number of adjacent neighbors for region i and σ
2
W is the
variance parameter. The joint probability distribution for W = (W1, · · · ,Wn)′ is expressed
as,
W |σ2W ∼MVN(0, σ2W
(
D −A)−1), (3.3)
where D is a diagonal matrix with Dii being the number of neighbours for the i
th region and
A is a matrix, such that Aij = 1, if i
th and jth regions are neighbors and Aij = 0, otherwise.
In model (2.1), Vi denotes the region-specific random effect capturing any residual varia-
31
tion that are not spatially correlated,
Vi ∼ N(0, σ2V ), (3.4)
where σ2V represents the variance parameter for Vi, i = 1, · · · , n.
The shared spatial frailty model is a special case of the full model with reduced random
effect structure only including W as the random effect term.
3.2 Bayesian Inference
To take the spatial and/or nonspatial Weibull regression can be implemented in a Bayesian
framework using Markov chain Monte Carlo (MCMC) procedures. The likelihood function
L(θ|t, δ,X) corresponding to the full frailty model (3.1) is expressed as,
L(θ|t, δ,X) =
n∏
i=1
ni∏
j=1
(
ρtρ−1ij e
β′Xij+Wi+Vi
)δij
exp
(−tρijeβ′Xij+Wi+Vi), (3.5)
where δij is the event indicator for the jth individual from the ith region, i = 1, · · · , n and
j = 1, · · · , ni; δij = 1 if the individual experienced the event and δij = 0 if censored.
Let θ = (ρ,β,W ,V , σ2W , σ
2
V )
′ denote the vector of all the parameters in the spatial
Weibull regression model and t = {tij} denote the collection of times to event or censoring,
X = {Xij} is the collection of covariate vectors and δ = {δij} is the collection of event
indicators for all subjects in all the geographical regions. The joint posterior distribution is
32
then expressed as
p(θ|t, δ,X) ∝ L(θ|t, δ,X)p(W |σ2W )p(V |σ2V )p(ρ)p(β)p(σ2W )p(σ2V ), (3.6)
where the first term in the right hand-side is the Weibull likelihood, the second and third
terms are the distributions for the spatially correlated and uncorrelated random effect terms,
as defined in (3.3) and (3.4), respectively.
The model specification in the Bayesian setup is completed by assigning prior distributions
for β, ρ, σ2W and σ
2
V . The normal prior is chosen for β ∼ N(0, σ20), while vague but proper
priors are chosen for ρ ∼ G(a, b); σ2W ∼ IG(c, d) and σ2V ∼ IG(c′, d′), where G and IG denote
the Gamma and inverse (reciprocal) Gamma distributions, respectively.
3.2.1 Gibbs Sampling Formulation
The Gibbs sampler [108] is used to update the parameters in the model, which requires draw-
ing samples sequentially from the full conditional distributions. The conditional distributions
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required by Gibbs sampling are given as follows:
β(l) ∼ β|ρ(l−1), σ2V (l−1),V l−1, σ2W (l−1),W (l−1), t, δ,X
ρ(l) ∼ ρ|β(l), σ2V (l−1),V l−1, σ2W (l−1),W (l−1), t, δ,X
σ2V
(l) ∼ σ2V |β(l), ρ(l),V l−1, σ2W (l−1),W (l−1), t, δ,X
V (l) ∼ V |β(l), ρ(l), σ2V (l), σ2W (l−1),W (l−1), t, δ,X
σ2W
(l) ∼ σ2W |β(l), ρ(l), σ2V (l),V l,W (l−1), t, δ,X
W (l) ∼W |β(l), ρ(l), σ2V (l),V l, σ2W (l), t, δ,X. (3.7)
More specifically:
β ∼
[ n∏
i=1
ni∏
j=1
(eδijβ
′Xij)e−t
ρ
ije
β′Xij+Wi+Vi
]
e
− β2
2σ20
ρ ∼
[ n∏
i=1
ni∏
j=1
(ρtρ−1ij )
δije−t
ρ
ije
β′Xij+Wi+Vi
]
ρa−1e−bρ
σ2V ∼
[ n∏
i=1
ni∏
j=1
eδijVie−t
ρ
ije
β′Xij+Wi+Vi
][ n∏
i=1
e
− (Vi)
2
2σ2
V
]
σ−c−1V e
−d
σ2
V
Vk ∼
(
eδkjVke−t
ρ
kje
β′Xkj+Wk+Vk)
e
− V
2
k
2(σV
2)2 ; k = 1, 2, . . . , n
σ2W ∼
[ n∏
i=1
ni∏
j=1
eδijWie−t
ρ
ije
β′Xij+Wi+Vi
]
σ−c
′−1
W e
−d′
σ2
W e
− 1
2σ2
W
W ′(D−A)W
W ∼
[ n∏
i=1
ni∏
j=1
eδijWie−t
ρ
ije
β′Xij+Wi+Vi
]
e
− 1
2(σW )
2W
′(D−A)W
. (3.8)
To implement Gibbs sampling, OpenBUGS software was utilized and the built-in function
car.normal was used to sample from the multivariate normal distribution for the spatial
random effect.
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3.2.2 Model Comparison Criteria
Deviance information criterion (DIC) is a Bayesian tool for model comparison. This criterion
was established by Spiegelhalter et al. (2002), and is an extension of frequentists’ criteria
which takes the number of parameters in the model into account [109]. This criterion is based
on the posterior distribution of the deviance statistic,
D(θ) = −2 log f(y|θ) + 2 log h(y), (3.9)
where f(y|θ) is the likelihood function for the observed data y, given the parameter vector
θ, and h(y) is the standardizing function of the data alone. The posterior mean of the de-
viance, D¯ = Eθ|y(D) measures the model adequacy and pD is effective number of parameters
measuring the model complexity, which is defined as
pD = Eθ|y(D)−D(Eθ|y(θ)) = D¯ −D(¯ˆθ), (3.10)
The DIC is then defined as,
DIC = D¯ + pD. (3.11)
Models with lower DIC scores are preferred as they achieve a more optimal combination of
fit and parsimony [109].
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3.3 Bayesian Model Checking Strategies
Checking the model fit is one of the steps required to confirm if the model used is appropriate
and is not under-fitting the data. One way to check the model fit is to define a scalar ‘test
quantity’ which is able to measure the discrepancies of the model fitted and the observed data.
Unlike the frequentist approach in which the test statistics are independent of the parameter
of interest, test quantities depend on both the observed data and (posterior distribution of)
parameters in Bayesian statistics and are denoted by T (y,θ) here, where y is the observed
data, and θ is the set of parameters gained after the model fit. Noted that in the survival
analysis context y represents time:
T (y,θ) =
N∑
i=1
(yi − E(yi|θ))2
var(yi|θ) , (3.12)
which is referred to as the Chi-square discrepancy measurement. Two other discrepancy
measurements can be defined as the minimum and maximum value of the observed survival
times,
T (y,θ) = ymin,
T (y,θ) = ymax.
(3.13)
Let y denote the observed data and yrep denote the replicated data. A posterior predic-
tive p-value is a summary measure which evaluates extremeness of T (y|θ) with respect to
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T (yrep|θ),
P (T (yrep,θ) ≥ T (y,θ)|y) =
∫
P (T (yrep,θ) ≥ T (y,θ)|θ)P (θ|y)dθ. (3.14)
The purpose of a p-value or diagnostic of fit is to reveal systematic differences between the
model prediction and the data. A p-value that is close to 0.50 represents adequate model fit,
whereas p-values near 0 or 1 indicate lack of fit [110].
3.4 Hip Fracture Data Analysis
In order to determine if there is any spatial correlation in the hazard of getting hip fracture
among the LTCFs at the FSA level after adjusting for various individual level risk factors,
we applied spatial frailty model to the hip fracture data. In our analysis, the geographic
unit is forward sortation area (FSA), since the exact spatial locations for the LTCFs are
not given due to the confidentiality issue. Post Canada defines an FSA as a geographical
region in which all postal codes start with the same three characters. The first letter of
an FSA code denotes a particular “postal district”, which, outside of Quebec and Ontario,
corresponds to an entire province or territory [111]. Our analysis includes 124 FSAs from
BC, while generalizations made at one level of spatial aggregation may not necessarily hold
at another level. Future work is needed to investigate the spatial effect at other levels of
spatial aggregation.
To determine if there is any spatial and/or non-spatial residual left unexplained by the
risk factors, we consider three competing models including the models: (1) with only the
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spatially correlated frailty term; (2) with only the spatial uncorrelated frailty term; and (3)
with both the spatially correlated and spatial uncorrelated frailty terms. The DIC goodness-
of-fit method is used to determine which model fits better and Bayesian model checking
strategies is used to examine the model fit. The computations were performed on a Windows
7 operator, with 8 Gigabyte ram and Core(Tm) i5-3337U CPU @ 1.80Hz system.
3.4.1 Models
The cohort comprises patients who meet the criteria outlined in Chapter 2. The covariates
include age, sex, urban-rural status, history of falls and hip fracture as well as start and end
points for patients inclusion, whether or not the elderly have developed hip fractures. The
models under comparison include the full model with Vi+Wi as the frailty, the spatial model
with Wi as the frailty and the non-spatial frailty model with Vi as the frailty. To be more
specific, the models are listed as follows:
(1) shared frailty model with independent frailty term:
h(tij) = ρt
ρ−1
ij e
ηij+Vi , (3.15)
(2) shared frailty model with spatially correlated frailty term:
h(tij) = ρt
ρ−1
ij e
ηij+Wi , (3.16)
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(3) shared frailty model with independent and spatially correlated frailty terms:
h(tij) = ρt
ρ−1
ij e
ηij+Vi+Wi , (3.17)
where ηij = β0 + β1Ageij + β2Fallsij + β3PriorHFij + β4UrbanRuralij, i = 1, 2, ..., n and
j = 1, 2, ..., ni such that n is the number of FSAs (n = 124) and ni is the number of patients in
the ith FSA. The priors for the parameters are specified as: βi ∼ N(0, 1), ρ, τV , τW ∼ G(1, 1)
such that σ2V = 1/τV and σ
2
W = 1/τW .
3.4.2 Results
Due to the computational burden analyzing the entire dataset (N = 36629), the dataset was
divided to two smaller datasets, one for males and another for females. Table 3.1 - 3.3 include
posterior means and posterior standard deviation (SD) along with the 95% credible intervals
of model parameter estimates, under the three competing models listed in the subsection
3.4.1, respectively.
Table 3.4 reports the Bayesian posterior predictive p-values when the discrepancy mea-
surements are Chi-square, min and max, as specified in (3.12) and (3.13). The results indicate
that all the models fit the data reasonably well with the Bayesian posterior predictive p-values
around 0.5. Table 3.5 reports the DICs for the three models. The comparison of the DICs
shows that the minimum value is cast by applying the non-spatial frailty model, which in-
dicates that the non-spatial frailty model performs the best as compared to the other two
competing models. As such, no spatial correlation in the hazard of hip fracture among the
FSAs were identified after accounting for known individual level risk factors. Further, the
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running time of non-spatial frailty was about the same as the running time of spatial frailty
and substantially smaller than the running time of the full model.
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Table 3.1: Posterior means (Mean), standard deviations (SD), 95% credible intervals
(CI) and the hazard ratios (HR) of the estimated parameters for the non-spatial frailty
model.
Females Males
Parameter Mean SD 95% CI HR Mean SD 95% CI HR
Age 0.04 0.04 (-0.04, 0.13) 1.04 0.13 0.07 (-0.01, 0.28) 1.14
Falls 0.39 0.05 (0.28, 0.49) 1.48 0.49 0.08 (0.32, 0.65) 1.63
Prior HF 0.51 0.09 (0.32, 0.68) 1.67 0.33 0.16 (0.000, 0.65) 1.39
Urban Rural -0.08 0.11 (-0.31, 0.12) 0.92 -0.02 0.18 (-0.37, 0.36) 0.98
σ2V 0.07 0.01 (0.05, 0.10) - 0.11 0.03 (0.07, 0.17) -
λ 0.75 0.08 (0.61, 0.94) - 0.78 0.14 (0.53, 1.08) -
ρ 1.12 0.02 (1.09, 1.16) - 1.16 0.03 (1.10, 1.22) -
Table 3.2: Posterior means (Mean), standard deviations (SD), 95% credible intervals
(CI) and the hazard ratios (HR) of the estimated parameters for the spatial frailty
model.
Females Males
Parameter Mean SD 95% CI HR Mean SD 95% CI HR
Age 0.05 0.04 (-0.03, 0.13) 1.05 0.13 0.07 (-0.02, 0.27) 1.14
Falls 0.39 0.05 (0.28, 0.49) 1.48 0.48 0.08 (0.32, 0.63) 1.62
Prior HF 0.50 0.09 (0.33, 0.68) 1.65 0.30 0.16 (-0.01, 0.59) 1.35
Urban Rural -0.06 0.09 (-0.24, 0.11) 0.94 -0.07 0.15 (-0.36, 0.22) 0.93
σ2W 0.09 0.02 (0.06, 0.14) - 0.15 0.04 (0.08, 0.24) -
λ 0.74 0.06 (0.62, 0.87) - 0.81 0.12 (0.60, 1.06) -
ρ 1.12 0.02 (1.08, 1.15) - 1.15 0.03 (1.09, 1.21) -
Table 3.3: Posterior means (Mean), standard deviations (SD), 95% credible intervals
(CI) and the hazard ratios (HR) of the estimated parameters for the full model.
Females Males
Parameter Mean SD 95% CI HR Mean SD 95% CI HR
Age 0.05 0.05 (-0.04, 0.13) 1.05 0.14 0.08 (-0.01, 0.28) 1.15
Falls 0.39 0.06 (0.28, 0.49) 1.48 0.50 0.09 (0.34, 0.67) 1.65
Prior HF 0.50 0.09 (0.33, 0.68) 1.65 0.35 0.16 (0.03, 0.65) 1.42
UrbanRural -0.05 0.12 (-0.29, 0.20) 0.95 -0.07 0.19 (-0.44, 0.30) 0.93
σ2V 0.08 0.02 (0.05, 0.11) - 0.11 0.03 (0.07, 0.18) -
σ2W 0.10 0.02 (0.06, 0.15) - 0.14 0.04 (0.08, 0.23) -
λ 0.73 0.09 (0.57, 0.91) - 0.79 0.15 (0.54, 1.11) -
ρ 1.13 0.02 (1.09, 1.16) - 1.17 0.03 (1.11, 1.24) -
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Table 3.4: Bayesian posterior predictive p-values for three discrepancy measurements
defined in (3.12) and (3.13).
Model Discrepancy Measures Bayesian p-value
T (yrep|θ) Females Males
Ch-Square 0.52 0.43
Non-spatial min 0.51 0.54
max 0.53 0.51
p-value 0.51 0.44
Spatial min 0.52 0.54
max 0.52 0.51
p-value 0.48 0.44
Full min 0.53 0.52
max 0.51 0.51
Table 3.5: Deviance information criterion (DIC) for competing models of in the hip
fracture data analysis.
Model DIC
Females Males
Non-spatial 5627.16 1681.36
Spatial 5628.46 1681.06
Full 5643.65 1693.64
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Chapter 4
Simulation Studies
In modeling a large scale survival data, it might be ideal to incorporate the spatial correla-
tion among the clusters in the model, when clusters exhibit spatial autocorrelation. However,
inference for these models is challenging. The Bayesian MCMC method, as the mostly com-
monly used inference procedure in spatial statistics, often poses computational challenges
modeling large scale spatially correlated data.
For example, in our data analysis presented in Chapter 2, more than 20 covariates can
be modeled through fitting an independent frailty model; however in order to model the
spatial correlation among the LTCFs, as presented in Chapter 3, only a few covariates can
be included in the model due to the limitation of computation rescouses. Additional, it only
takes a few minutes to fit an independent frailty model through generalized linear mixed
effect model in SAS (by selecting an efficient optimization algorithm), whereas it took at
least 10 hours to fit a spatial frailty model with only limited number of covariates.
In spite of the non-significance of the spatial autocorrelation in our motivating example,
we strive to understand how much benefit we can gain through modeling the spatial effect in
a large scale survival data. Further, we aim to investigate if there is any bias and efficiency
loss in the estimated regression coefficients under the misspecified correlation structure and
if the bias and efficiency loss depends on the percentage of censoring, the number of clusters
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and the relative strength of the residual spatial correlation.
4.1 Simulation Design
To examine the bias and efficiency loss in the estimated regression coefficients under mis-
specified residual correlation structure, we conducted a series of simulation studies.
First, we consider simulating the failure/censoring time from the full model as:
h(tij) = ρt
ρ−1
ij e
β0+β1X1ij+β2X2ij+Wi+Vi , (4.1)
where β0 = log(λ), where λ is the scale parameter of Weibull distribution, and
W |σ2W ∼MVN(0, σ2W
(
D −A)−1), (4.2)
where D −A is the neighborhood structure and
Vi ∼ N(0, σ2V ). (4.3)
A simulated dataset was derived by dividing the area into 5×5 = 25 equally sized squares.
We also considered increase the number of areas as 10 × 10 = 100 and 16 × 16 = 196. The
covariates are simulated as X1ij ∼ N(0, 1) and X2ij ∼ Bernoulli(0.5) in order to make the
simulation studies general applicable. To evaluate the percentage of censoring on the bias
of the estimated regression coefficients, we considered varying the percentage of censoring
as 20%, 70%, 85%, 90% and 95% under the right censoring mechanism. These censoring
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variables are generated from binomial distribution. The fixed values for parameters other
than σ2V have been chosen purposefully. The fixed values are: λ = e
β0 = .55, ρ = 1.5, β1 = 2,
β2 = 1.5, σ
2
W = 5. To evaluate the impact of the residual spatial correlation on the estimated
regression coefficients, we specify σ2V = 0, 1, 4, 15. That is, for σ
2
V = 0, the model is reduced
to be model with only the spatially correlated random effect, and as σ2V increases over 1, 4,
and 15, the spatial effect becomes less dominant compared with the overall residual variation.
We created 100 of the defined simulated datasets for each simulation scenario and on
each dataset, three models were fitted including: (1) the full model with the independent
and spatially correlated random effect terms, (2) the spatial model with only the spatially
correlated random effect term and (3) the non-spatial model with only the spatially uncor-
related random effect term.
We assigned a vague Normal prior with mean 0 and variance 1000, N(0, 1000), to βi’s, a
Gamma distribution prior with mean 0 and variance 1000, G(0.0001, 0.0001), for ρ, τV , τW ,
where τV = 1/σ
2
V and τW = 1/σ
2
W . Two independent sequences of Markov chain simula-
tion with overdispersed starting points were generated. Each chain ran for 15,000 MCMC
iterations using a burn-in of 5000, and thin number 10, which were sufficient to ensure con-
vergence based on trace plots and Rˆ statistic. The simulation were carried out in R version
3.0.3, using parallel computing capabilities of a high performance computing system.
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4.2 Simulation Results
Tables 4.1- 4.6 show the percent relative bias (RB) [112] of posterior means, mean square
error (MSE) for the posterior means and the coverage probability (CP) of the 95% credible
interval for the parameter estimate for λ, ρ, β1, β2, σ
2
V , σ
2
W , respectively, with varying number
of clusters (25, 100 and 196) and percent of censorship (20, 70, 85, 90 and 95), when the
values for σ2V and σ
2
W are set as 4.
The results for λ as presented in Table 4.1 indicate that all the three models yield sub-
stantial bias in estimating λ when the number of clusters is small, i.e 25 clusters; however as
the number of clusters increases, the RB and MSE decrease at the same level of percentage
of censorship. By increasing the percentage of censorship given the same number of cluster
size, RB and MSE increases. Under all scenarios, the RB and MSE tends to be larger for the
spatial model and not much difference between non-spatial and the full models. Further, the
CP under the spatial model is substantially lower than the non-spatial and the full models,
especially when the percentage of censoring and the number of clusters is low.
The RB, MSE and CP for the posterior estimate of the parameter ρ are presented in
Table 4.2. The results indicate that as the percentage of censoring increases, the RB and
MSE increase and CP decreases for all three models. Nevertheless, when the percentage of
censoring is less than 90%, bias remains small and coverage probability were approximatively
0.95, especially when the number of clusters is large. The RB and MSE for the spatial model
appear to be larger than the full and non-spatial model; whereas the CP tends to be lower
for the spatial model as compared with the full and non-spatial model.
As for the posterior estimates of the regression coefficients β1 and β2, presented in Tables
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4.3 and 4.4. The patterns or RB, MSE and CP are consistent with the posterior estimate for
ρ (Table 4.2). When the percentage of censoring is not extremely high (> 90%), and when
the number of clusters is high, all the models perform reasonably well with the RB < 5%
and the CP is close to 95%; however, when the number of clusters is small, especially when
the percentage of censoring is high, the spatial model yield much larger RB, MSE and lower
CP. For example, when the number of clusters is 25 and the percentage of censoring is 95%,
the RB under the spatial model is 36.629 and the CP dropped to as low as 0.65. Although
the RB for the full and non-spatial models are also high in this scenario, the CPs are all over
80%.
Table 4.4 shows similar pattern for estimates for all the three models, but shows that
estimates are more sensitive to size of clusters and censorship. For instance, when number
of clusters is 25, the estimate of β2 are biased for censorship equal or greater than 70%; and
for larger clusters, censorship equal or over 85% and 90% result in relative bias over 5%. In
all scenarios, non-spatial and full model are not significantly different, but always perform
better than spatial model.
In general, under all scenarios, the RB, MSE and CP depend on the percentage of cen-
soring the the number of clusters in the data. The spatial model yields the most inaccurate
and unstable posterior estimates as compared to the full and the non-spatial models. The
performance of the non-spatial model and the full model are fairly comparable, which indi-
cates the gains of modeling the spatial correlation in addition to the non-spatial correlation
is only marginal.
Tables 4.5 and 4.6 present the RB, MSE and CP for the variance components σ2W and σ
2
V
for the spatially correlated random effect and spatially uncorrelated random effect, respec-
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tively. The results indicate that the full model performs reasonably well in estimating the
σ2W and σ
2
V when the percentage of censoring is lower than 90% and the number of clusters
is above 100. By contrast, the spatial model completely missed modeling the spatial random
effect with zero coverage probability and substantial RB and MSE. The 95% credible interval
for the variance component of the spatially uncorrelated effect also completely missed the
true parameter, but the RB (Table 4.6) is much smaller as compared with the RB for variance
component of the spatially correlated random effect term (Table 4.5). To better display the
results, we also generated the boxplots of the posterior mean estimates of λ, ρ, β1, β2, σ
2
W
and σ2V , as displayed in Figures 4.1-4.6.
Tables 4.7-4.12 contain the average of posterior means and their 95% credible intervals
along with the average of estimates for Rˆ over the repeatedly simulated data. The results
show that by increasing the percentage of censorship and decreasing the number of clusters,
the posterior mean of λ tend to overestimate its true value and the posterior means of ρ, β1
and β2 tend to overestimate their true values, and the credible intervals for all parameters
become wider. By comparing the three competing models, when the percentage of censoring
is not overly high, i.e. < 95% and the number of clusters is not very low, i.e. > 25,
the parameter estimates based on the non-spatial model are fairly close to the parameter
estimates based on the full model (true model), as compared to the spatial model. The
Rˆ estimates are all close to 1 and do not vary across different simulation scenarios, which
indicates the convergence of the MCMC chains.
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Table 4.1: Percent relative bias (%RB), mean square error (MSE) and coverage prob-
ability (CP) of the estimated λ based on the non-spatial model, spatial model and the
full model, when the data is simulated from the full model. The true value for λ = 0.55.
Cluster 25 100 196
%Censor Model %RB MSE CP %RB MSE CP %RB MSE CP
20 non-spatial 35.440 0.122 0.960 6.840 0.016 0.990 3.169 0.001 1.000
Spatial 20.455 0.110 0.275 1.994 0.015 0.220 0.090 0.001 0.370
Full 30.514 0.114 0.940 6.498 0.017 0.940 2.391 0.001 0.960
70 non-spatial 40.000 0.133 0.960 1.722 0.000 0.990 3.293 0.001 0.980
Spatial 21.524 0.111 0.516 2.527 0.016 0.424 0.182 0.001 0.600
Full 36.092 0.131 0.940 7.016 0.018 0.960 2.529 0.001 0.970
85 non-spatial 45.590 0.163 0.950 12.255 0.026 0.960 5.568 0.001 0.990
Spatial 27.082 0.120 0.656 5.478 0.021 0.646 1.766 0.001 0.747
Full 42.373 0.159 0.930 10.943 0.026 0.920 4.612 0.001 0.959
90 non-spatial 54.506 0.217 0.950 12.452 0.022 0.990 7.718 0.013 0.970
Spatial 34.838 0.164 0.790 4.903 0.016 0.880 2.781 0.010 0.870
Full 51.981 0.218 0.930 10.562 0.020 0.960 6.548 0.012 0.930
95 non-spatial 73.380 0.337 0.920 27.983 0.066 0.960 11.051 0.016 1.000
Spatial 44.388 0.189 0.880 16.842 0.045 0.880 5.703 0.012 0.960
Full 77.557 0.389 0.900 25.209 0.061 0.930 10.260 0.015 0.990
Table 4.2: Percent relative bias (%RB), mean square error (MSE) and coverage prob-
ability (CP) of estimator of ρ based on the non-spatial model, spatial model and the
full model, when the data is simulated from the full model. The true value for ρ = 1.5.
Cluster 25 100 196
%Censor Model %RB MSE CP %RB MSE CP %RB MSE CP
20 non-spatial 1.383 0.000 0.960 0.288 0.000 0.960 0.174 0.000 0.960
Spatial 1.700 0.000 0.956 0.378 0.000 0.950 0.188 0.000 0.960
Full 1.370 0.000 0.960 0.377 0.000 0.950 0.194 0.000 0.960
70 non-spatial 3.107 0.011 0.930 0.568 0.000 0.960 0.543 0.000 0.970
Spatial 3.506 0.012 0.926 0.699 0.000 0.939 0.685 0.000 0.980
Full 3.070 0.011 0.940 0.573 0.000 0.940 0.601 0.000 0.990
85 non-spatial 5.642 0.028 0.910 2.014 0.001 0.930 0.824 0.000 0.940
Spatial 7.490 0.034 0.885 2.614 0.001 0.919 1.497 0.000 0.929
Full 5.271 0.026 0.910 2.145 0.001 0.930 0.892 0.000 0.948
90 non-spatial 11.853 0.055 0.890 2.731 0.014 0.920 1.591 0.001 0.950
Spatial 15.533 0.081 0.810 4.074 0.017 0.870 2.846 0.001 0.930
Full 11.106 0.049 0.920 2.881 0.014 0.910 1.794 0.001 0.950
95 non-spatial 19.250 0.113 0.850 8.140 0.034 0.930 5.500 0.022 0.930
Spatial 29.186 0.221 0.630 12.809 0.060 0.840 9.833 0.039 0.820
Full 16.295 0.089 0.890 8.408 0.034 0.910 5.908 0.022 0.900
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Table 4.3: Percent relative bias (%RB), mean square error (MSE) and coverage prob-
ability (CP) of estimator of β1 based on the non-spatial model, spatial model and the
full model, when the data is simulated from the full model. The true value for β1 = 2.
Cluster 25 100 196
%Censor Model %RB MSE CP %RB MSE CP %RB MSE CP
20 non-spatial 1.862 0.011 0.920 0.237 0.000 0.930 0.038 0.000 0.910
Spatial 2.325 0.010 0.945 0.364 0.000 0.950 0.052 0.000 0.910
Full 1.840 0.011 0.930 0.359 0.000 0.950 0.057 0.000 0.910
70 non-spatial 3.202 0.029 0.930 0.325 0.000 0.930 0.549 0.000 0.990
Spatial 3.534 0.030 0.926 1.015 0.001 0.949 0.683 0.000 1.000
Full 3.157 0.028 0.930 0.874 0.001 0.950 0.609 0.000 0.990
85 non-spatial 8.292 0.093 0.880 1.955 0.016 0.940 0.742 0.010 0.960
Spatial 10.075 0.101 0.865 2.590 0.018 0.939 1.349 0.011 0.949
Full 7.937 0.089 0.900 2.082 0.016 0.940 0.748 0.010 0.959
90 non-spatial 15.569 0.170 0.860 4.322 0.039 0.910 2.485 0.018 0.960
Spatial 19.437 0.225 0.830 5.611 0.044 0.850 3.719 0.022 0.950
Full 14.903 0.159 0.870 4.406 0.039 0.920 2.710 0.018 0.950
95 non-spatial 29.830 0.436 0.830 12.624 0.121 0.860 7.039 0.065 0.860
Spatial 36.629 0.618 0.650 16.787 0.177 0.780 11.113 0.098 0.830
Full 27.408 0.380 0.870 12.882 0.122 0.840 7.381 0.067 0.870
Table 4.4: Percent relative bias (%RB), mean square error (MSE) and coverage prob-
ability (CP) of the estimated β2 based on the non-spatial model, spatial model and the
full model, when the data is simulated from the full model. The true value for β2 = 1.5.
Cluster 25 100 196
%Censor Model %RB MSE CP %RB MSE CP %RB MSE CP
20 non-spatial 2.633 0.018 0.960 0.584 0.000 0.990 0.227 0.000 0.930
Spatial 2.989 0.018 0.934 0.723 0.000 0.990 0.250 0.000 0.930
Full 2.634 0.018 0.950 0.710 0.000 0.970 0.250 0.000 0.940
70 non-spatial 7.996 0.055 0.910 1.164 0.001 0.990 0.599 0.010 0.920
Spatial 8.826 0.055 0.916 1.844 0.014 0.919 0.720 0.010 0.930
Full 8.027 0.055 0.920 1.641 0.014 0.920 0.660 0.010 0.930
85 non-spatial 16.503 0.132 0.970 4.045 0.036 0.910 2.324 0.017 0.960
Spatial 18.620 0.150 0.938 4.960 0.038 0.889 2.774 0.017 0.970
Full 16.317 0.130 0.970 4.366 0.036 0.910 2.447 0.017 0.959
90 non-spatial 24.809 0.246 0.940 5.972 0.061 0.910 4.725 0.025 0.950
Spatial 27.354 0.274 0.920 7.470 0.064 0.900 5.673 0.027 0.950
Full 24.132 0.239 0.950 6.134 0.061 0.920 4.771 0.025 0.940
95 non-spatial 48.099 0.697 0.840 18.534 0.150 0.920 13.033 0.088 0.940
Spatial 51.381 0.768 0.780 22.133 0.187 0.900 16.786 0.115 0.870
Full 47.128 0.677 0.840 18.778 0.154 0.930 13.397 0.090 0.920
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Table 4.5: Percent relative bias (%RB), mean square error (MSE) and coverage prob-
ability (CP) of the estimated σ2V based on the non-spatial model, spatial model and the
full model, when the data is simulated from the full model. The true value for σ2W = 5.
Cluster 25 100 196
%Censor Model %RB MSE CP %RB MSE CP %RB MSE CP
20 Spatial 465.040 646.380 0.000 554.910 798.890 0.000 581.540 860.590 0.000
Full 18.340 18.450 0.970 3.450 15.770 0.950 1.840 10.960 0.930
70 Spatial 435.760 590.370 0.000 536.280 751.360 0.000 565.690 818.340 0.000
Full 10.450 13.260 0.930 4.080 17.590 0.930 2.260 10.800 0.950
85 Spatial 371.990 484.590 0.000 491.850 650.010 0.000 536.970 742.450 0.000
Full 6.540 12.280 0.930 3.660 16.310 0.930 1.500 12.010 0.980
90 Spatial 262.020 282.870 0.000 462.200 605.070 0.000 509.140 693.270 0.000
Full 5.740 10.240 0.940 6.520 24.100 0.950 1.310 13.680 0.920
95 Spatial 99.880 108.620 0.000 320.010 333.670 0.000 368.350 404.690 0.000
Full 24.810 5.480 0.950 1.280 12.640 0.930 2.190 13.300 0.960
Table 4.6: Percent relative bias (%RB), mean square error (MSE) and coverage prob-
ability (CP) of the estimated σ2W based on the non-spatial model, spatial model and the
full model, when the data is simulated from the full model. The true value for σ2V = 4.
Cluster 25 100 196
%Censor Model %RB MSE CP %RB MSE CP %RB MSE CP
20 Non-spatial 31.910 4.640 0.000 36.160 3.000 0.000 39.600 3.140 0.000
Full 5.650 2.320 1.000 1.570 1.010 0.920 1.850 0.510 0.900
70 Non-spatial 28.430 4.500 0.000 39.270 2.200 0.000 38.700 3.080 0.000
Full 6.530 2.430 1.000 0.280 1.120 0.960 2.060 0.570 0.910
85 Non-spatial 20.300 4.820 0.000 31.890 2.900 0.000 37.950 3.160 0.000
Full 11.910 2.950 0.990 4.140 1.370 0.960 1.870 0.600 0.920
90 Non-spatial 3.740 3.880 0.000 30.990 3.650 0.000 37.870 3.530 0.000
Full 23.690 3.090 0.990 5.160 1.890 0.950 1.540 1.410 0.920
95 Non-spatial 18.260 3.710 0.000 17.180 2.920 0.000 25.910 3.390 0.000
Full 31.550 3.810 0.990 17.620 2.350 0.990 10.690 1.970 0.940
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Table 4.7: Posterior mean, %95 credible interval (CI) and Rˆ for the estimated λ based
on the non-spatial model, spatial model and the full model, when the data is simulated
from the full model. The true value for λ = 0.55.
Cluster 25 100 196
%Censor Model Mean %95 CI Rˆ Mean %95 CI Rˆ Mean %95 CI Rˆ
Non-spatial 0.74 0.30 - 1.56 1.003 0.59 0.36 - 0.90 1.003 0.57 0.40 - 0.78 1.003
20 Spatial 0.66 0.56 - 0.77 1.001 0.56 0.52 - 0.61 1.001 0.55 0.52 - 0.58 1.001
Full 0.72 0.33 - 1.41 1.003 0.59 0.39 - 0.86 1.002 0.56 0.42 - 0.74 1.002
Non-spatial 0.77 0.31 - 1.63 1.002 0.56 0.44 - 0.71 1.002 0.57 0.40 - 0.79 1.003
70 Spatial 0.67 0.49 - 0.87 1.001 0.56 0.48 - 0.65 1.001 0.55 0.49 - 0.61 1.001
Full 0.75 0.33 - 1.50 1.003 0.59 0.38 - 0.87 1.002 0.56 0.41 - 0.75 1.002
Non-spatial 0.80 0.31 - 1.75 1.002 0.62 0.36 - 0.98 1.002 0.58 0.39 - 0.83 1.003
85 Spatial 0.70 0.42 - 1.08 1.002 0.58 0.45 - 0.73 1.002 0.56 0.46 - 0.67 1.001
Full 0.78 0.33 - 1.62 1.003 0.61 0.38 - 0.92 1.003 0.58 0.41 - 0.79 1.002
Non-spatial 0.85 0.32 - 1.89 1.003 0.62 0.35 - 1.01 1.003 0.59 0.39 - 0.87 1.003
90 Spatial 0.74 0.39 - 1.27 1.002 0.58 0.41 - 0.78 1.002 0.57 0.44 - 0.71 1.002
Full 0.84 0.34 - 1.78 1.002 0.61 0.36 - 0.95 1.003 0.59 0.40 - 0.83 1.003
Non-spatial 0.95 0.33 - 2.31 1.003 0.70 0.36 - 1.26 1.004 0.61 0.36 - 0.96 1.004
95 Spatial 0.79 0.35 - 1.58 1.003 0.64 0.39 - 0.99 1.003 0.58 0.40 - 0.82 1.003
Full 0.98 0.34 - 2.35 1.003 0.69 0.37 - 1.19 1.003 0.61 0.38 - 0.93 1.004
Table 4.8: Posterior mean, %95 credible interval (CI) and Rˆ for the the estiamted
ρ based on the non-spatial model, spatial model and the full model, when the data is
simulated from the full model. The true value of ρ = 1.5.
Cluster 25 100 196
%Censor Model Mean %95 CI Rˆ Mean %95 CI Rˆ Mean %95 CI Rˆ
Non-spatial 1.48 1.36 - 1.60 1.001 1.50 1.44 - 1.56 1.001 1.50 1.45 - 1.54 1.001
20 Spatial 1.47 1.35 - 1.60 1.001 1.49 1.43 - 1.56 1.001 1.50 1.45 - 1.54 1.001
Full 1.48 1.36 - 1.60 1.001 1.49 1.43 - 1.56 1.001 1.50 1.45 - 1.54 1.001
Non-spatial 1.45 1.25 - 1.67 1.001 1.49 1.41 - 1.57 1.001 1.49 1.41 - 1.57 1.001
70 Spatial 1.45 1.24 - 1.66 1.001 1.49 1.38 - 1.60 1.002 1.49 1.41 - 1.57 1.001
Full 1.45 1.25 - 1.67 1.001 1.49 1.39 - 1.60 1.001 1.49 1.41 - 1.57 1.001
Non-spatial 1.42 1.11 - 1.75 1.002 1.47 1.31 - 1.64 1.002 1.49 1.36 - 1.62 1.002
85 Spatial 1.39 1.08 - 1.72 1.003 1.46 1.30 - 1.63 1.002 1.48 1.35 - 1.61 1.002
Full 1.42 1.12 - 1.75 1.002 1.47 1.31 - 1.64 1.002 1.49 1.36 - 1.62 1.002
Non-spatial 1.32 0.96 - 1.73 1.003 1.46 1.25 - 1.69 1.004 1.48 1.31 - 1.65 1.004
90 Spatial 1.27 0.91 - 1.68 1.004 1.44 1.23 - 1.67 1.004 1.46 1.29 - 1.63 1.004
Full 1.33 0.98 - 1.74 1.003 1.46 1.24 - 1.68 1.003 1.47 1.31 - 1.64 1.004
Non-spatial 1.21 0.75 - 1.83 1.005 1.38 1.05 - 1.75 1.009 1.42 1.15 - 1.71 1.009
95 Spatial 1.06 0.65 - 1.65 1.006 1.31 0.98 - 1.68 1.009 1.35 1.09 - 1.65 1.009
Full 1.26 0.80 - 1.87 1.005 1.37 1.06 - 1.74 1.008 1.41 1.15 - 1.70 1.009
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Table 4.9: Posterior mean, %95 credible interval (CI) and Rˆ for the estimated β1
based on the non-spatial model, spatial model and the full model, when the data is
simulated from the full model. The true value of β1 = 2.
Cluster 25 100 196
%Censor Model Mean %95 CI Rˆ Mean %95 CI Rˆ Mean %95 CI Rˆ
Non-spatial 1.96 1.77 - 2.16 1.001 2 1.90 - 2.09 1.001 2.00 1.93 - 2.07 1.001
20 Spatial 1.95 1.76 - 2.15 1.001 1.99 1.90 - 2.09 1.001 2.00 1.93 - 2.07 1.001
Full 1.96 1.77 - 2.16 1.001 1.99 1.90 - 2.09 1.001 2.00 1.93 - 2.07 1.001
Non-spatial 1.94 1.60 - 2.28 1.001 1.99 1.87 - 2.12 1.001 1.99 1.86 - 2.12 1.001
70 Spatial 1.93 1.60 - 2.27 1.001 1.98 1.81 - 2.15 1.001 1.99 1.86 - 2.12 1.001
Full 1.94 1.61 - 2.28 1.001 1.98 1.81 - 2.16 1.001 1.99 1.86 - 2.12 1.001
Non-spatial 1.83 1.33 - 2.37 1.002 1.96 1.70 - 2.24 1.002 1.99 1.78 - 2.19 1.002
85 Spatial 1.80 1.30 - 2.33 1.002 1.95 1.68 - 2.22 1.002 1.97 1.77 - 2.18 1.002
Full 1.84 1.34 - 2.37 1.002 1.96 1.69 - 2.23 1.002 1.99 1.78 - 2.19 1.002
Non-spatial 1.69 1.08 - 2.35 1.002 1.91 1.57 - 2.28 1.003 1.95 1.69 - 2.23 1.003
90 Spatial 1.61 1.01 - 2.28 1.003 1.89 1.54 - 2.25 1.003 1.93 1.66 - 2.20 1.003
Full 1.70 1.10 - 2.36 1.003 1.91 1.57 - 2.27 1.002 1.95 1.68 - 2.22 1.004
Non-spatial 1.40 0.59 - 2.32 1.004 1.75 1.23 - 2.32 1.007 1.86 1.44 - 2.32 1.007
95 Spatial 1.27 0.52 - 2.15 1.004 1.66 1.15 - 2.23 1.007 1.78 1.36 - 2.23 1.008
Full 1.45 0.63 - 2.38 1.004 1.74 1.23 - 2.31 1.007 1.85 1.44 - 2.30 1.008
Table 4.10: Posterior mean, %95 credible interval (CI) and Rˆ for the estimated β2 =
1.5 based on the non-spatial model, spatial model and the full model, when the data is
simulated from the full model. The true value of β2 = 1.5.
Cluster 25 100 196
%Censor Model Mean %95 CI Rˆ Mean %95 CI Rˆ Mean %95 CI Rˆ
Non-spatial 1.46 1.21 - 1.71 1.001 1.49 1.37 - 1.62 1.001 1.50 1.40 - 1.59 1.001
20 Spatial 1.46 1.20 - 1.71 1.001 1.49 1.36 - 1.61 1.001 1.50 1.40 - 1.59 1.001
Full 1.46 1.21 - 1.71 1.001 1.49 1.36 - 1.61 1.001 1.50 1.40 - 1.59 1.001
Non-spatial 1.38 0.94 - 1.82 1.001 1.48 1.32 - 1.64 1.001 1.49 1.32 - 1.66 1.001
70 Spatial 1.37 0.93 - 1.81 1.001 1.47 1.25 - 1.69 1.001 1.49 1.32 - 1.66 1.001
Full 1.38 0.94 - 1.82 1.001 1.48 1.25 - 1.70 1.001 1.49 1.32 - 1.66 1.001
Non-spatial 1.25 0.59 - 1.93 1.001 1.44 1.09 - 1.79 1.002 1.47 1.20 - 1.73 1.002
85 Spatial 1.22 0.56 - 1.89 1.002 1.43 1.08 - 1.78 1.002 1.46 1.20 - 1.72 1.002
Full 1.26 0.59 - 1.93 1.001 1.43 1.09 - 1.78 1.001 1.46 1.20 - 1.73 1.002
Non-spatial 1.13 0.30 - 1.97 1.002 1.41 0.95 - 1.88 1.002 1.43 1.08 - 1.78 1.002
90 Spatial 1.09 0.27 - 1.93 1.002 1.39 0.93 - 1.85 1.002 1.41 1.07 - 1.76 1.002
Full 1.14 0.31 - 1.98 1.002 1.41 0.95 - 1.87 1.002 1.43 1.08 - 1.78 1.002
Non-spatial 0.78 -0.37 - 1.94 1.002 1.22 0.54 - 1.94 1.003 1.30 0.76 - 1.87 1.003
95 Spatial 0.73 -0.36 - 1.83 1.002 1.17 0.51 - 1.86 1.004 1.25 0.72 - 1.80 1.003
Full 0.79 -0.37 - 1.96 1.002 1.22 0.54 - 1.92 1.003 1.30 0.76 - 1.86 1.004
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Table 4.11: Posterior mean, %95 credible interval (CI) and Rˆ for the estimated σ2W
based on the spatial model and the full model, when the data is simulated from the full
model. The true value for σ2W = 5.
Cluster 25 100 196
%Censor Model Mean %95 CI Rˆ Mean %95 CI Rˆ Mean %95 CI Rˆ
20 Spatial 28.25 15.41 - 50.30 1.001 32.75 24.31 - 43.82 1.001 34.08 27.52 - 42.05 1.001
Full 5.92 0.37 - 23.06 1.007 5.17 0.82 - 15.71 1.007 5.09 1.31 - 12.59 1.008
70 Spatial 26.79 13.05 - 50.63 1.001 31.81 22.54 - 44.08 1.001 33.28 25.93 - 42.27 1.001
Full 5.52 0.37 - 22.85 1.005 5.20 0.81 - 15.87 1.007 4.89 1.22 - 12.42 1.008
85 Spatial 23.60 8.66 - 51.13 1.002 29.59 18.92 - 44.12 1.002 31.85 22.96 - 42.95 1.002
Full 5.33 0.33 - 23.42 1.003 5.18 0.76 - 16.13 1.007 4.93 1.05 - 13.27 1.008
90 Spatial 18.10 4.65 - 45.56 1.003 28.11 15.89 - 45.33 1.003 30.46 20.11 - 43.81 1.003
Full 4.71 0.31 - 21.26 1.004 5.33 0.75 - 17.15 1.009 4.93 1.01 - 13.82 1.009
95 Spatial 9.99 0.85 - 38.02 1.006 21.00 7.48 - 43.12 1.008 23.42 10.94 - 41.69 1.008
Full 3.76 0.28 - 20.06 1.005 4.94 0.48 - 18.16 1.011 4.89 0.76 - 15.12 1.013
Table 4.12: Posterior mean, %95 credible interval (CI) and Rˆ for the estimated σ2V
based on the non-spatial model and the full model, when the data is simulated from
the full model. The true value of σ2V = 4
Cluster 25 100 196
%Censor Model Mean %95 CI Rˆ Mean %95 CI Rˆ Mean %95 CI Rˆ
20 Non-spatial 5.28 2.90 - 9.35 1.001 5.45 4.05 - 7.28 1.001 5.58 4.52 - 6.88 1.001
Full 3.77 0.98 - 7.97 1.009 4.06 2.11 - 6.09 1.012 4.07 2.65 - 5.49 1.01
70 Non-spatial 5.14 2.56 - 9.60 1.001 2.43 1.88 - 3.10 1.001 5.55 4.35 - 7.02 1.001
Full 3.74 0.89 - 8.23 1.006 4.01 2.00 - 6.21 1.011 4.08 2.59 - 5.63 1.01
85 Non-spatial 4.81 1.91 - 10.11 1.002 5.28 3.45 - 7.74 1.002 5.52 4.04 - 7.36 1.002
Full 3.52 0.69 - 8.68 1.004 3.83 1.72 - 6.35 1.01 4.07 2.34 - 5.95 1.013
90 Non-spatial 4.15 1.30 - 9.74 1.002 5.24 3.09 - 8.26 1.003 5.51 3.75 - 7.78 1.003
Full 3.05 0.53 - 8.34 1.004 3.79 1.51 - 6.79 1.012 4.06 2.13 - 6.30 1.011
95 Non-spatial 3.27 0.54 - 10.70 1.005 4.69 1.97 - 9.00 1.007 5.04 2.66 - 8.41 1.008
Full 2.74 0.37 - 9.64 1.005 3.30 0.86 - 7.36 1.013 3.57 1.33 - 6.73 1.017
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Figure 4.1: Boxplots of the posterior mean estimates of λ from the 100 samples
generated from the full model. The reference line shows the true value of λ.
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Figure 4.2: Boxplots of the posterior mean estimates of ρ from the 100 samples
generated from the full model. The reference line shows the true value of ρ.
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Figure 4.3: Boxplots of the posterior mean estimates of β1 from the 100 samples
generated from the full model. The reference line shows the true value of β1.
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Figure 4.4: Boxplots of the posterior mean estimates of β2 from the 100 samples
generated from the full model. The reference line shows the true value of β2.
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Figure 4.5: Boxplots of the posterior mean estimates of σ2V from the 100 samples
generated from the full model. The reference line shows the true value of σ2V .
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Figure 4.6: Boxplots of the posterior mean estimates of σ2W from the 100 samples
generated from the full model. The reference line shows the true value of σ2W .
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Chapter 5
Conclusion and Future Work
In this thesis, motivated by the computational challenges encountered in modeling spatial
correlation in a real application with large scale survival data, we used simulations to assess
the efficiency loss in the parameter estimates if residual spatial correlation is present but
using the spatially uncorrelated random effect term in the model.
This is particularly relevant in many public health or medical studies in modeling large
scale survival data, when researchers strive to build complicated spatial frailty model to model
spatial correlation in the residuals. To model such complex statistical problems, Bayesian
MCMC methods are often used. The method comes at the price of slow mixing rates and
heavy computation cost, which may render it impractical for data intensive applications.
Further, the information on detailed neighboring structure is often not released to public due
to confidentiality or when it is not clear what sort of spatial or neighborhood structure may
be appropriate.
By simulating the data from the full model including the spatially correlated and iid
random effect terms and then fit the models with reduced random effect structures, our sim-
ulation study shows that under all the simulation scenarios, by increasing the percentage of
censorship, relative bias (RB) and mean square error (MSE) increase and the coverage prob-
ability (CP) become much lower than the nominal level. As well, as the number of clusters
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increases, the performances in all the models improve. In particular, when the percentage of
censoring is low and the number of clusters is high, all the competing models perform equiv-
alently well in estimating the regression and Weibull parameters. The performance of the
three models differs when the percentage of censoring is high with small number of clusters
or when estimating the variance components. To be more specific, the RB and MSE tend to
be larger for the model which only includes the spatial term and do not tend to differ that
much between the non-spatial and the full models. Further, the CP under the spatial model
is substantially lower than the nominal level as compared to the non-spatial and the full
models, especially when the percentage of censoring and the number of clusters are low. This
implies that the shared frailty model with only the spatially correlated random effect may not
be sufficient enough to govern the total residual variation, whereas the simpler model with
only the spatially uncorrelated random effect term performs surprisingly well in estimating
the regression and Weibull parameters compared with the true model. Noted that these
results are based on one specific adjacency matrix. It would be interesting to investigate
the impact of different adjacency structures on the parameter estimates in the spatial frailty
model through further simulation studies.
In short, the shared frailty model with the independent frailty term provides a straight-
forward method for estimating the covariate effects for large scale survival data, which is
computationally infeasible for the spatial frailty model, particularly when exploring the ef-
fects of a large number of covariates is of interests.
This is not to say that the shared frailty model with independent frailty term should be
preferred over the spatial frailty model in all cases. Indeed, when the primary goal of inference
is predicting the hazard for specific covariates group, additional care need to be given due
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to the bias in the scale parameter associated with the Weibull distribution. Future research
can be carried out to examine the frailty model with different random effect structures when
the primary goal is estimating the hazard functions.
One alternative to the shared frailty model is to simply use the random effect logistic
regression model for analyzing the dichotomized event outcome variable. In this case, com-
putations become remarkably cheap, but the interpretation of regression parameters differs.
However, when the disease of interest is rare, such as in our motivating example related to
hip fracture in LTCFs, the log odds and log relative risk (hazard ratio) become even more
similar [113]. Knowing that the percent of hip fracture in our data analysis was only around
8%, one potential future research is to apply a random effect logistic regression on the hip
fracture data to estimate hazard ratios.
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Appendix A
Appendix
A.1 Optimization Methods
A.1.1 Adaptive Gaussian Quadrature Optimization
Let β denote the vector of fixed-effects parameters and θ the vector of covariance parame-
ters. θ includes the G-side parameters and a possible scale parameter φ, provided that the
conditional distribution of the data contains such a scale parameter. θ−φ is the vector of the
G-side parameters. The marginal distribution of the data for subject i in a mixed model can
be expressed as
p(yi) =
∫
...
∫
p(yi|bi, β, φ)p(bi|θ−φ) dbi. (A.1)
Noted that this multi-dimensional integral will be reduced to a one-dimensional integral
in case of an intercept random model, or a shared frailty model.
Let Nq denote the number of quadrature points in each dimension (for each random effect)
and r denotes the number of random effects. The adaptive Gaussian quadrature approximate
to the multi-dimensional integral (A.1) is
∫
...
∫
p(yi|bi, β, φ)p(bi|θ−φ) dbi ≈ 2n2 |f ′′(yi, β, θ; bˆi)|− 12
Σ
Nq
j1=1
...Σ
Nq
jr=1
[
p(yi|ai, β, φ)p(aj|θφ)
r∏
q=1
e
z2jqwjq
]
, (A.2)
where bˆi are called empirical Bayes estimates which minimize
− log(p(yi|ai, β, φ)p(aj|θ−φ)) = f(yi, β, θ; bi). (A.3)
Also
aj = bˆi +
√
1
2
|f ′′(yi, β, θ; bˆi)|− 12 z?j (A.4)
such that z?j = [zj1 , ..., zjr ] is a point on the r-dimensional quadrature grid, z = [z1, ..., zq ] are
standard quadrature points, w = [w1, ..., wNq ] are Gauss-Hermite weights, and
f ′′(yi, β, θ; bˆi) =
∂2f(yi, β, θ; bi)
∂bi∂b′i
|bˆi (A.5)
Having this approximation for the integral, we can estimate the likelihood function. Let
f(β, ρ,X, tij, δij, σ
2
V |Vi) =
(
ρtρ−1ij e
β′Xij+Vi
)δij exp (−tρijeβ′Xij+Vi). Hence,
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l(β, ρ,X, δ, σ2V ) = log
(
L(β, ρ,X, δ, σ2V )
) ≈
log n
2
n∑
i=1
ni∑
j=1
log
[
f ′′(β, ρ,X, tij, δij, σ2V |Vˆi)
−1
2
Q∑
q=1
(
ρtρ−1ij e
β′Xij+ai,q
)δije−tρijeβ′Xij+ai,q e z?q 22 wq],
(A.6)
where ai,q = Vˆi + σ
2
V f
′′(β, ρ,X, tij, δij, σ2V |Vˆ )−
1
2 z?q such that Vˆi are empirical bayes estimates
which maximize
f ′′(β, ρ,X, tij, δij, σ2V |Vˆ ) =
∂2f(β, ρ,X, tij, δij, σ
2
V |Vˆ )
∂V 2i
|Vˆ . (A.7)
A.1.2 Quasi-Newton Optimization
Suppose f(x) is a function in IRp and one needs to maximize it. Let
pk = xk+1 − xk,
qk = ∇f(xk)−∇f(xk+1)
(A.8)
Then the Davidon-Fletcher-Powell (DFP) inverse-Hessian approximation is [86]:
Bk+1 = Bk +
pkp
T
k
pTk qk
− Bkqkq
T
kBk
qTkBkqk
, (A.9)
where B0 is usually Ip. If one defines δk = argminf(xk + δkRk) and rk = −Bk∇f(xk), the
update step is
xk+1 = xk + δkrk. (A.10)
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Appendix B
Appendix
B.1 Verification of Weibull Assumption
The Weibull assumption for the Weibull frailty model is examined by checking the log(− log(S(t)))
vs. log(t) plot, which should give approximately a straightly line if the Weibull distributed
assumption of baseline survival time is satisfied.
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Figure B.1: Plot of log(− log(S(t))) vs. log(t).
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Figure B.2: Plot of log(− log(S(t))) vs. log(t) stratified by age and sex variables.
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Figure B.3: Plot of log(− log(S(t))) vs. log(t) stratified by age, sex and falls history
variables.
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